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Genetic deletion or pharmacological blockade of the CB1 receptor has been 
reported to impair extinction learning in aversive conditioning (i.e., conditioned fear and 
Morris water maze) paradigms, but not in operant procedures in which food 
reinforcement is earned.  It is difficult to discern whether the differential effects caused 
by CB1 receptor disruption on extinction result from the hedonics (i.e., aversive vs. 
appetitive) or is related to the required responses associated with these disparate tasks.  In 
order to evaluate whether the hedonics is the determining factor, we used either aversive 
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(i.e., escape from bright lights and air turbulence) or appetitive (i.e., to gain access to 
water) motivators in the Barnes maze task, a model in which mice are required to enter a 
hidden goal box.  Administration of the CB1 receptor antagonist, rimonabant, disrupted 
extinction learning under aversive conditions, but not under appetitive conditions.  This is 
the first study to show a differential effect of rimonabant on extinction in a task that 
required identical motor behaviors, but only differed in hedonic nature of the reinforcer.   
In addition, genetic ablation of CB1 receptor signaling impaired acquisition of the task 
under both aversive and appetitive conditioning procedures.  Conversely, enhancing 
endocannabinoid signaling, via genetic deletion of the FAAH enzyme, accelerated 
acquisition of the task under aversive, but not appetitive, conditioning procedures.    
Accordingly, these data strongly support the hypothesis that the endogenous cannabinoid 
system plays a necessary role in the extinction of aversively motivated behaviors, but is 
expendable in appetitively motivated behaviors.  While these findings underscore 
concerns over potential side effects associated with CB1 receptor antagonists, they also 
suggest that stimulating the endogenous cannabinoid system may be a pharmacological 
approach to treat maladaptive behaviors that arise from stress or trauma.   
 
 
 
 
 
 
INTRODUCTION 
 
 
 
THE ENDOCANNABINOID SYSTEM 
 
 
 
“Numerous observers have described the Indian hemp as producing in the 
natives of the East, who familiarly use it instead of intoxicating spirits, 
sometimes a heavy, lazy state of agreeable reverie, from which the 
individual may be easily roused to discharge of any simple duty – 
sometimes a cheerful, active state of inebriation causing him to dance, 
sing and laugh, provoking the venereal appetitive, and increasing the 
desire for food – and sometimes a quarrelsome drunkenness, leading to 
acts of violence.  During this condition pain is assuaged and spasm 
arrested….On the whole, it is a remedy which deserves a more extensive 
inquiry than any hitherto instituted.”  (Christison, 1848) 
 
Documented use of marijuana as a therapeutic spans thousands of years, treating 
an unparalleled range of general [e.g. pain, edema, migraines] and specific [e.g. infantile 
convulsions, hemorrhoids, malaria, sexual dysfunction] afflictions.    In spite of its 
intriguing history of medical use, European physicians such as O’Shaughnessy, 
Christison, and Aubert-Roche began documenting side effects, such as cognitive 
disruption, subjective effects, and anxiety (Christison, 1848).  Eventually, these reports 
would shift public opinion of marijuana to that of an intoxicant following the 20th 
century.  This shift in public attitude regarding marijuana, from therapeutic to intoxicant, 
would eventually spread around the world, and in the United States, resulted in the 
federal anti-marihuana act of 1937 and its classification as a controlled substance 
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(National Commission on Marihuana and Drug Abuse, 1972).   Despite its legal status 
being restricted in most western countries, the prolonged debate over potential medical 
utilization has continued.  Inexplicably, the therapeutic potential of manipulating the 
system marijuana activates, as an alternative to cannabis use, rarely enters the public 
debate.  
 The discovery of delta-9-tetrahydrocannabinol (THC) as the primary active 
constituent of marijuana (Gaoni and Mechoulam, 1964) opened the door for scientific 
investigation into what is currently referred to as the endocannabinoid system.  The 
system is comprised of THC’s primary sites of action, the CB1 (Matsuda et al., 1990) and 
CB2 receptors (Munro et al., 1993), as well as THC’s endogenous counterparts, the 
endocannabinoids.  This class of  THC-like compounds, distinguished by their activity at 
the CB1 and CB2 receptors, include anandamide [AEA] (Devane et al., 1992), 2-
arachidonoylglycerol [2-AG] (Mechoulam et al., 1995; Sugiura et al., 1995), noladin 
ether (Hanus et al., 2001), virodhamine (Porter et al., 2002), and N-
arachidonoyldopamine (Huang et al., 2002).  Enzymes responsible for the inactivation of 
the two primary endocannabinoids, anandamide and 2-AG, are respectively fatty acid 
amide hydrolase [FAAH] (Cravatt et al., 1996) and monoacylglycerol lipase [MAGL] 
(Dinh et al., 2002).   
Unlike the vast majority of traditional neurotransmitters (e.g., dopamine, 
acetylcholine), endocannabinoids such as anandamide and 2-AG are not stored in 
vesicles, but are synthesized and released ‘on demand’ from membrane bound precursors 
(Di Marzo et al., 1994).  The biosynthesis of anandamide occurs through multiple 
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pathways, common to each is the formation of the precursor N-arachidonoyl-
phosphatidylethanolamine (NAPE).  The enzyme N-acyl transferase (NAT), catalyzes the 
transfer of arachidonic acid from phosphatidylcholine (PC) to phosphatidylethanolamine 
(PE), resulting in the formation of NAPE.  Previous research in rat cortical neurons has 
implicated the involvement of two intracellular second messengers controlling NAT 
activity: Ca2+ and cyclic AMP (cAMP).   While cAMP is thought to enhance the activity 
of NAT via protein kinase A-dependent phosphorylation, evidence for calcium-
dependence is supported by the observation that NAT is inactive in the absence of Ca2+ 
(Cadas et al., 1996).  Three different pathways have been identified through which NAPE 
is converted into AEA.  First, PLC catalyzes the formation of the intermediary p-AEA, 
which is subsequently converted into AEA by phosphatases.  Alternatively, anandamide 
can be produced by NAPE-PLD.  However, this pathway appears to be a ‘salvage 
pathway,’ utilized when the PLC/phosphatase pathway is compromised  (Schmid et al., 
1990; Cadas et al., 1997; Sugiura et al., 2002; Sugiura and Waku, 2002; Leung et al., 
2006; Liu et al., 2006; Gomez-Ruiz et al., 2007; Liu et al., 2008).  Finally, conversion of 
NAPE, by sPLA2/Abhd4, to lysoNAPE, which can be subsequently converted into AEA 
by Lyso-PLD.   Inactivation of anandamide is primary mediated by the enzyme FAAH, 
producing arachidonic acid and ethanolamine.  However, evidence also exists for cyclo-
oxygenase-2, and lipo-oxygenase as enzymatic regulators of anandamide degredation 
(Kozak and Marnett, 2002). 
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The biosynthesis of 2-AG is thought to occur through two pathways, 
distinguished by the formation of diacylglycerol (DAG).  In the first, phospholipase C 
(PLC) hydrolyzes phosphoinositides (PI) to produce DAG  (Stella et al., 1997).  
Alternatively, phosphatidic acid (PA) phosphohydrolase can hydrolyze PA to synthesize 
DAG (Bisogno et al., 1999).  Common to both pathways, DAG lipase then catalyzes 
DAG hydrolysis to form the endocannabinoid 2-AG (Farooqui et al., 1989; Bisogno et 
al., 2003).   Mediating the metabolism of 2-AG are the enzymes monoacylglycerol lipase 
(MGL) (Konrad et al., 1994), ABHD12, ABHD6 (Blankman et al., 2007), and FAAH (Di 
Marzo et al., 1998).  Collectively, MGL, ABHD12, and ABHD6 account for ~98% of 2-
AG hydrolysis [respectively: ~85%, 9% and 4%], indicating a negligible role for FAAH 
(Blankman et al., 2007).  Irrespective of the degrading enzyme, arachidonic acid and 
glycerol are the products of 2-AG degradation (Di Marzo et al., 1999). Together, these 
receptors, endogenous agonists, and the enzymes regulating them, comprise the 
endocannabinoid system.   
 The CB1 receptor is one of the most abundant receptors in the CNS, exhibiting its 
highest densities in the cerebellum, hippocampus, striatum, globus palladum, and 
substantia nigra (Herkenham et al., 1991; Matsuda et al., 1993).   The CB1 receptor, and 
the predominantly peripheral CB2, belong to the seven trans-membrane receptor family of 
G-protein-coupled receptors (GPCR).  Interestingly, the CB1 receptor is the most 
abundant GPCR found in the brain (Howlett et al., 1990; Herkenham et al., 1991).  
Further classification of cannabinoid receptors puts them in the family of inhibitory 
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GPCRs known as Gi/o.  Activation of the cannabinoid receptors results in a cascade of 
effects, beginning with the inhibition of adenylyl cyclase, subsequent decrease in cAMP, 
and ensuing decrease in protein kinase A dependent phosphorylation (Devane et al., 
1988).  Additionally, activation can produce inhibition of calcium through N (Mackie and 
Hille, 1992), L (Gebremedhin et al., 1999), and P/Q type ion channels (Twitchell et al., 
1997) as well as activation of inwardly rectifying K channels.  Collectively, the effects 
serve to decrease neurotransmitter release, primarily through presynaptic inhibitory 
processes (Mackie et al., 1995).   
 
 
 
 
 
CANNABINOIDS AND COGNITION 
 
 
 
 The past 30 years have seen great strides in our understanding of how CB1 
agonists affect learning and memory.  However, these advances have not been easy, often 
requiring novel approaches to address various inconsistencies or uncertainties.  
Moreover, factors such as cognitive terminology hamper the interpretation and 
extrapolation of data.  For example, the terms learning, memory, performance, and 
cognition are all related and at times employed interchangeably.  Across academic fields, 
however, these terms can have different definitions and connotations and can be devided 
into numerous different cognitive processes.  Further classification of memory includes 
working (short-term) and reference (long-term) memory.  A third category, recognition 
memory, is based on an animal’s inherent desire to explore unfamiliar objects, scents, or 
conspecifics (Wotjak, 2005).  The inherent difficulty then, is that the investigator must 
separate these different facets of cognition when designing an experiment to determine, 
and accurately report, which aspect is affected.   
 To clarify the terminology used in this dissertation, memory is defined as changes 
in an animal’s behavior some time after learning, and involves processes of acquisition, 
consolidation and retrieval.  Memory acquisition is defined as a learned response.  For 
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example, acquisition in contextual conditioned fear involves the association between a 
context, and a shock.  During consolidation, learned information is encoded into memory 
by alterations in interneuronal communication, moving the memory from a labile, to a 
more fixed state (Abel and Lattal, 2001).  The persistence in these changes can then be 
categorized by short-term and long-term memory based on the duration of memory 
retention, and biosynthetic changes in memory consolidation (McGaugh, 2000).   Upon 
reintroduction into the conditioning context, the previously learned association (memory) 
is retrieved, and results in behavioral alterations.  In the example of contextual fear 
conditioning, reintroduction into the conditioning context results in the retrieval of 
memory associating prior experience in the context with shock, and is behaviorally 
manifested as freezing behavior.  The persistence of a memory is limited by either its 
decay, or the inability to retrieve it.  Conversely, the original memory may be actively 
suppressed by an inhibitory learning process known as extinction learning (Wotjak, 
2005). 
 While this is somewhat of a superficial overview of learning, it serves to 
introduce a greater problem facing behavioral research.  Varvel & Lichtman (2005) 
provide a precise summary:  
“…learning and memory is not directly measured, but is inferred based on 
changes in performance.  In particular alterations in attentional, 
sensorimotor, and motivational processes can affect performance, 
independently of cognition.” 
     Perhaps the greatest issue for the researcher is the inescapable reliance on 
interpreting performance as a manifestation of learning.  Bouton & Moody (2004) 
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expertly discuss these issues in an enlightening review.   Almost immediately, the authors 
place emphasis on the central idea that ‘what an animal does in an…experiment is not the 
same as what it knows.’  Learning, the authors continue, represents a hypothetical 
psychological and physiological change within the brain and is a separate entity from 
performance, the expression of learning through behavior (Bouton and Moody, 2004).   
 In the early 20th century, Edward Tolman was the first to illustrate the separation 
of learning and performance.  In their innovative experiment of latent learning, the 
authors trained two groups of rats to navigate a maze; the first group was rewarded for 
successful completion of the maze task, while the second was not.  As might be expected, 
rats rewarded for completing the task performed to a superior degree, committing fewer 
errors than their non-rewarded counterparts.  However, once the non-rewarded group 
received reward for completing the task, their efficiency at completing the task increased 
on the following trial.  The authors concluded that even though the behavior of the non-
reinforced group did not reflect learning, it was nonetheless taking place.  Thus, the 
function of reward was to motivate the animal to perform (Tolman and Honzik, 1930).  
Summarized by Bouton & Moody (2004), ‘learning is not the same as performance.  
Motivation is required for translation.’ 
Measuring learning independent of confounds including, emotional state, ambulatory 
function, attentional state, and motivation are a primary concern for an investigator.  
These variables represent a challenge to investigators in the field of cannabinoids, as 
genetic and pharmacological manipulation of the endocannabinoid system can affect all 
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of the above-mentioned processes, at times making it difficult to infer the occurrence of 
learning.   As will be discussed, controlling for non-mnemonic factors was a primary 
consideration during the design of the studies presented in this dissertation. 
 
 
 
 
BACKGROUND & SIGNIFICANCE 
 
 
 
“For the Egyptians, hemp is the plant par excellence, not for the uses they 
make of it in Europe and many other countries, but for its peculiar effects.  
The hemp cultivated in Egypt is indeed intoxicating and narcotic.”  
(Rouyer, 1810) 
 
 
Marijuana use has long been associated with perturbations of working memory 
that reflects adapting one’s behavior to new information (Varvel and Lichtman, 2005).    
One of the predominant models for studying this task is the delayed non-match to sample 
(DNMS) or the delayed match to sample (DMTS) operant task.  These experiments rely 
on the subject’s ability to remember a stimulus (e.g. previous choice) over a variable 
delay, an increase in which requires a greater demand on working memory.  Typically, 
the paradigm involves the presentation of a sample stimulus, followed by a delay in 
absence of the stimulus.  Following the delay, subjects are exposed to both the sample 
stimulus and a novel stimulus.  The task requires that the subject makes an active 
response, (e.g., a lever press), indicating the novel-stimulus (DNMS) or the previously 
exhibited sample stimulus (DMTS) for reward.  Based on the correct percentage of 
responses, THC (2mg/kg) administration delay-dependently impaired performance, 
resulting in performance indistinguishable from hippocampally-lesioned rats pre-trained 
in the task (Hampson and Deadwyler, 1998; Deadwyler et al., 2007).     
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 Results from a two-component operant task in rats provides further evidence for 
THC disrupting working memory (Mallet and Beninger, 1998).  In this experiment, 
subjects pressed one of two levers, depending on the presence of two different stimuli 
(cued conditional discrimination component).  Training prior to drug administration 
allowed subjects to learn to make the correct choice on all subsequent trials.  By 
definition, in trained animals, this component requires reference memory as the subjects 
had already learned the task (Honig, 1978).  In the second component of the session 
(delayed non-match to position), no cues were presented and rats were required to press 
the lever opposite the one pressed during the first component.  Even after learning this 
new rule, greater-than-chance responding could only be achieved by remembering which 
of the two levers was pressed during the first component of that particular trial.  By 
definition, this component requires working memory (Honig, 1978).  THC, as well as 
anandamide co-administered with the non-specific amidase inhibitor 
phenylmethylsulfonyl fluoride (PMSF), disrupted the working memory aspect, but left 
reference memory intact.  Consistent with a CB1 receptor mechanism of action, 
administration of the CB1 antagonist, rimonabant, reversed the performance deficits 
caused by exogenously administered CB1 agonists.  
 In addition to impairing memory in operant tasks, THC impairs learning in spatial 
memory paradigms, which generally rely on the use of spatial cues in the environment to 
navigate a maze.  Performance in these paradigms requires hippocampal-dependent 
processes, an area characterized by dense CB1 receptor localization, as well as taking 
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advantage of an animal’s natural tendencies such as foraging or predator avoidance 
(Olton, 1987; Lichtman et al., 2002).  For example, THC dose-dependently disrupts 
performance in the 8-arm radial arm maze.  During acquisition of the task, rats use spatial 
cues to find food in all but one of the arms.  Subjects then must remember the unexplored 
arm on a subsequent exposure following a temporal delay.  The dependent measure, 
errors prior to entering the correct arm, assesses performance.  Lichtman et al., (1995) 
demonstrated that systemic administration of THC disrupted performance as assessed by 
the increased number of errors committed.  In a follow-up study THC’s disruptive effect 
was exhibited as delay-dependent, and dose-dependently reversed by rimonabant 
administration (Lichtman and Martin, 1996).  
Another commonly used method of assessing spatial memory is the Morris water 
maze, a task requiring subjects to use spatial cues to locate and swim to a hidden 
platform.  THC administration disrupted performance in a working memory version of 
this task, where the location of the hidden platform is variable, exhibited by longer path 
lengths and latencies to locate the hidden platform.  THC also disrupted a reference 
memory version of the task, in which the hidden platform location was consistent across 
trials.  However, the disruptive effects occurred at much higher doses (100 mg/kg) when 
compared to the working memory model (3 mg/kg), suggesting an increased 
susceptibility to THC’s disruptive effects in working memory compared to reference 
memory (Varvel et al., 2001).   
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Studies utilizing exogenous cannabinoid administration provide rationale for the 
involvement of the endogenous cannabinoid (eCB) system in cognitive processes, but 
cannot closely mimic the actions of an endogenous system firmly integrated in neural 
circuits and eliciting precise biochemical responses to specific contexts (Varvel and 
Lichtman, 2005).  Moreover, confounding the interpretation of the data are side effects 
associated with exogenous administration of CB1 agonists, such as alterations in motor 
behavior and motivation.  The development of genetic and pharmacological tools specific 
to endogenous CB1 receptor signaling have provided alternative means to study the eCB 
system.  The following section is designed to review the literature surrounding the use of 
these tools, as well as their effects on acquisition and extinction learning.  Moreover, the 
focus is specific to the work presented in this dissertation, exploring acquisition and 
extinction following pharmacological CB1 receptor antagonism, as well as acquisition 
effects associated with the deletion of the CB1 receptor and FAAH enzyme. 
 
 
 
THE eCB SYSTEM AND ACQUISITION 
 
 
RIMONABANT 
 
 
The CB1 receptor antagonist/inverse agonist, rimonabant, has been a highly useful 
tool to investigate the endocannabinoid system (Rinaldi-Carmona et al., 1994).  As a 
pharmacotherapeutic, rimonabant has shown potential for treating multiple disorders.  
Clinical trials revealed its utility in treating type 2 diabetes, increasing HDL-LDL ratios, 
and reducing risk factors associated with cardiovascular disease (Despres et al., 2005; 
Van Gaal et al., 2005; Pi-Sunyer et al., 2006; Scheen et al., 2006).  Likewise, published 
research has shown its value as a possible pharmacotherapeutic for treating dependence 
associated with ethanol (Arnone et al., 1997), tobacco (Cahill and Ussher, 2007) opiates 
(Navarro et al., 2001), cocaine (De Vries et al., 2001), and cannabis (Tanda et al., 2000; 
Justinova et al., 2005).   
Currently under the trade name Acomplia® (Zimulti® in the United States), 
rimonabant has won approval for the treatment of obesity in the European Union, and is 
marketed in countries including Argentina, Austria, Denmark, Finland, Germany, Ireland, 
Norway, Sweden, Greece, Brazil, Mexico, and the United Kingdom.  Conversely, in the 
United States an FDA advisory panel (2007) composed of outside experts voted 
unanimously in favor of rejecting approval citing inadequate safety data.  More recently, 
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the possibility of FDA approval for rimonabant was dealt a severe setback following the 
release of data from a meta-analysis of four clinical trials.  In their study, the authors 
reported a 40% increase in adverse events ranging from depression and anxiety to 
suicidal thoughts, despite the exclusion of patients with a history of depression or 
psychiatric illnesses during clinical trials (Christensen et al., 2007).   Currently, it would 
appear that sales within the United States might never materialize.  Nonetheless, 
rimonabant remains a useful pharmacological tool to investigate cannabinoid receptor 
agonists as well as the eCB system. 
In rodent models of learning and memory, rimonabant exhibits a spectrum of 
cognitive effects; improving, disrupting, and at times exhibiting no effect on learning.   
Terranova et al., (1996) published the first report showing that rimonabant administration 
enhanced memory in a social recognition paradigm.  In this paradigm, the amount of time 
a mature mouse spent investigating a juvenile conspecific during their first meeting vs. 
follow-up meetings, measures ‘remembering.’  Thus, decreased time spent investigating 
on the second exposure to the juvenile would indicate that they remembered the first 
exposure.  In this paradigm, rimonabant administration 5 min after the first exposure, but 
not 15 or 90 min after, decreased the time spent investigating during the second exposure.  
Given the narrow window in which rimonabant administration improved memory 
functions, the data would suggest an enhancement of consolidation (Terranova et al., 
1996).   
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 Reports from the radial arm maze task further support rimonabant enhancing 
memory processes.  In the acquisition of this procedure, rats have access to seven of the 
eight arms.  In the test phase six hours later, errors prior to entering the remaining arm 
provide a measure of how well the subject remembered.   Rimonabant administration 
prior to the first acquisition phase, but not after the first phase or 20-min before the test 
phase, decreased the number of re-entry errors (Lichtman, 2000; Wise et al., 2007).  In a 
similar radial arm maze task, rimonabant was observed to dose-dependently decrease re-
entry errors when administered immediately after the acquisition phase, but not before 
the test phase (Wolff and Leander, 2003).  Possible explanations for differential results 
when administration of rimonabant occurred after the test phase include differences in 
procedure (blocking one vs. four arms), or the choice of vehicle.  Alternatively, when 
administered after the test phase, the absence of enhanced acquisition may be a result of 
the drug failing to absorb quickly enough to affect consolidation, or a critical period in 
which consolidation processes are active.    
 Similarly, rimonabant administration before or immediately after the acquisition 
phase, but not the test phase, enhances avoidance behavior in the elevated T-Maze 
(Takahashi et al., 2005), and intrahippocampal administration prior to training enhances 
memory in food-storing birds for the location of hidden food rewards (Shiflett et al., 
2004).  Collectively, the results from procedures associating enhanced acquisition with 
rimonabant suggest the drug is acting on, and improving, the acquisition and/or 
consolidation of memory rather than retrieval.        
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 Procedural differences appear to provide a possible explanation for reports in 
which rimonabant administration fails to affect acquisition of other tasks.  For example, 
rimonabant administration does not affect acquisition rates in the Morris water maze 
spatial memory task (Varvel et al., 2005), passive avoidance tasks (Mazzola et al., 2003; 
Niyuhire et al., 2007), operant conditioning (Mallet and Beninger, 1998; Niyuhire et al., 
2007), or conditioned fear (Marsicano et al., 2002; Suzuki et al., 2004; Kamprath et al., 
2006; Niyuhire et al., 2007) paradigms.  The collective literature regarding cognitive 
alterations following rimonabant administration supports two conclusions.  First, 
rimonabant enhances acquisition and/or consolidation of memory, but does not affect 
retrieval.  Second, procedural components appear critical in determining the absence or 
expression of rimonabant’s effects.  Specifically the temporal components, but not the 
hedonic nature of the reinforcer, may be primary.  Thus, tasks demanding memory 
processes lasting for minutes to hours show enhancement, while those on the order of 
seconds, do not (Lichtman et al., 2002).   However, this explanation appears insufficient 
as rimonabant has been shown to enhance performance in a delayed non-match to sample 
paradigm.  At delays longer than 10s, rimonabant administration resulted in a greater 
percentage of correct responses, as well as increasing the frequency of ‘strong’ SmR code 
strength, a measure of hippocampal information encoding at the time of sample 
responding during DNMS trials.  Furthermore, rimonabant impaired acquisition of delay 
eyeblink conditioning (Kishimoto and Kano, 2006).  In this study, the conditioned 
stimulus (tone) co-terminates with the unconditioned stimulus (shock), and the learned 
association between US and CS results in a conditioned startle response (eyeblink) during 
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subsequent CS presentations.  During acquisition of the task, rimonabant treated subjects 
exhibited a significant reduction in the percentage of conditioned responses compared to 
vehicle treatment.  However, indistinguishable performance occurred between treatment 
groups during the first acquisition day, and acquisition differences between groups were 
not observed until subsequent acquisition trials had been performed.  Thus, the relevance 
of these data, with respect to the hypothesis of Lichtman et al., (2002), is undetermined.  
 
 
 
CB1 -/- MICE 
 
 
Converging evidence provided by genetic correlates of pharmacological 
antagonism provide an alternative means of verifying results from pharmacological 
studies by inactivating specific biological processes genetically.  Furthermore, utilizing 
both genetic and pharmacological approaches provides evidence that results are 
independent of confounds associated with drug administration (e.g., inverse agonism, 
non-specific effects, interactions, alternative sites of action) and/or genetic knockout 
animals (i.e., compensatory mechanisms, genetic drift, downstream developmental 
changes).  To this end, CB1 receptor knockout mice provide a complementary approach 
along with the use of CB1 receptor antagonists to block eCB signaling.   Reibaud et al., 
(1999) were the first to show enhanced acquisition in CB1 -/- mice during a two-trial 
object recognition task.   In this experiment, mice received a ten-min open field trial in 
the presence of a novel object.  Following a 3, 24, or 48 h delay, subjects were re-
exposed in the presence of both the familiar, as well as a new, unfamiliar object.  
Comparing the amount of time spent investigating each object provides a measure for 
how well the subject ‘remembers’ the first encounter, and chance occurrence is set at 
50%.  Following a 3 h delay, both genotypes exhibited an indistinguishable increase in 
time spent analyzing the new object compared to the familiar object.  However, 24 and 
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48 h delays resulted in chance performance in wild-type mice, while CB1 -/- mice 
continued to show preference for investigating the unfamiliar object.  These results were 
later replicated using CB1 -/- mice on the CD-1 background (Maccarrone et al., 2002), in 
both old and young mice.  While the effect was repeated in both young and old knockout 
mice, the authors reported age-related adaptive changes in knockout mice.  Specifically, 
deletion of the CB1 receptor resulted in an age-related increase in FAAH activity, and 
subsequent decrease in AEA content.  Furthermore, in both cases these changes exhibited 
the most profound alterations in the hippocampus.     
Evidence for improved acquisition in CB1 -/- mice has also been exhibited in an 
active avoidance test (Martin et al., 2002).  In this paradigm, the subject is placed in an 
apparatus composed of two chambers connected by a door.  The subject must learn that 
the onset of a light is predictive of an impending shock, and avoiding the shock requires 
charging into the unlit compartment.  While both genotypes exhibited similar baseline 
performance on day one, CB1 -/- mice showed a significant enhancement of avoidance 
learning, demarcated by increased conditioned charges compared to wild-type mice.   
Converging electrophysiological evidence provides further support for enhanced 
acquisition in CB1 -/- mice.  Long-term potentiation (LTP) is thought to underlie the 
formation of memory by strengthening synaptic connections following repeated 
stimulation of a synaptic pathway.  In vitro analysis of hippocampal CB1 -/- brain slices 
reveals an enhanced capacity to strengthen synaptic connections, resulting in an almost 
50% greater response compared to wild-type controls (Bohme et al., 2000). 
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Under certain conditions, CB1 -/- mice exhibit impaired acquisition.  In models of 
cued conditioned fear, subjects learn to associate the onset of a cue with impending 
shock.  Following repeated pairings, analysis of freezing behavior in probe trials where 
the cue is presented in a new context denotes acquisition of the task.   In this paradigm, 
genetic ablation of the CB1 receptor leaves acquisition unaffected (Marsicano et al., 
2002; Cannich et al., 2004; Kamprath and Wotjak, 2004).  Similarly, contextual 
conditioned fear involves testing the subject in the same context as training.  Unlike 
results from the cued procedure, CB1 -/-, but not CB1 +/+, mice on the CD-1 background 
exhibited very little freezing upon re-exposure to the context, resembling results from 
unshocked CB1 -/- and +/+ control mice (Mikics et al., 2006).  While the strain 
differences may have influenced the results, differences in brain areas associated with the 
two procedures may also account for the disparity in results.  Lesions of the amygdala 
impair cue-induced fear, while lesions of the hippocampus impair context-induced fear 
(Phillips and LeDoux, 1994; McNish et al., 1997; Bast et al., 2003; Ahi et al., 2004).  
Cued conditioned fear is largely reliant on the amygdala, whereas contextual conditioned 
fear is dependent on the dorsal hippocampus.  
Conditioned eyeblink paradigms are categorized primarily by temporal 
differences in the presentation of the unconditioned stimulus (US) and conditioned 
stimulus (CS).  Delay paradigms require US (shock) and CS (tone) co-termination, 
whereas trace paradigms utilize a stimulus-free interval between US and CS presentation.  
Whereas delay paradigms are dependent on the cerebellum (McCormick and Thompson, 
1984; Thompson et al., 1997), trace conditioning requires both the cerebellum and 
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hippocampus (Moyer et al., 1990; Weiss et al., 1999; Kishimoto et al., 2006).   
Comparison of CB1 -/- and +/+ mice in the delay procedure reveals acquisition deficits in 
-/-, but not +/+ mice (Kishimoto and Kano, 2006). Furthermore, electromyogram (EMG) 
recordings on the final acquisition day revealed significantly lower average amplitudes in 
response to the CS, presumably due to behavioral differences in conditioned responding.   
Investigation into potential confounds revealed no significant genotype differences with 
regards to spontaneous eyeblink frequency, motor coordination, startle responses, or the 
intensity of the US to elicit an eyeblink response.    In opposition to the acquisition of the 
delay conditioning paradigm, CB1 -/- and +/+ mice showed equal acquisition 
performance in the trace conditioning procedure.    
Recent reports underscore the importance of age as a determining factor when 
studying the cognitive performance of CB1 -/- mice.  Bilkei-Gorzo et al., (2005) 
demonstrated that deletion of the CB1 receptor results in age-specific cognitive effects.  
In the social recognition paradigm, subjects are exposed to a novel, juvenile conspecific 
on two occasions separated by a variable interval.  A decrease in time investigating the 
partner on the second exposure is indicative of remembering.  Young (6-7 weeks of age) 
CB1 -/- mice exhibited enhanced acquisition compared to wild-type age-matched 
controls.  However, a striking decline in performance was observed in mature (3-5 
months) CB1 -/- mice, exhibiting impairment similar to old (14-17 months) wild-type 
mice.  To determine if the observed effects were strain-dependent, the experiment was 
replicated using juvenile and mature CB1 -/- and +/+ mice on the CD-1 background.  
Again, young CB1 -/- exhibited enhanced retention compared to controls, as well as a 
23 
 
rapid age-related decline in performance of CB1 -/- mice.   Performance of the same 
groups in an operant condition paradigm revealed a similar age-related decline in the 
cognitive performance of CB1 -/- mice.  Conversely, deficits in the wild-type group were 
only observed in the old group, exhibiting impaired performance similar to mature CB1 -
/- mice.  Analysis of neuronal density within the different age groups provides an 
intriguing correlate to the behavioral deficits. Compared to wild-type mice, CB1 -/- mice 
show a rapid decline in the density of hippocampal neurons as they age, in the most 
extreme case exhibiting a 70% reduction in old knockout mice compared to their age-
matched controls. 
The expression of cognitive differences in CB1 -/- mice appears to depend on the 
hedonic nature of the reinforcer (e.g. aversive vs. appetitive).  In an operant conditioning 
procedure in which subjects were given food-reward for a correct nose-poke response of 
an illuminated hole, CB1 -/- mice exhibited normal acquisition of the task (Holter et al., 
2005).   Importantly, CB1 -/- mice showed reduced motivation to work for reward 
following moderate food restriction.  Increasing the level of deprivation proved necessary 
to achieve equivalent performance between genotypes.  Furthermore, the age of the mice 
was the same as mature subjects from the experiment by Bilkei-Gorzo et al., (2005).  As 
this group reported an age-dependent decline in performance in a similar operant task, 
effects observed by Holter et al., may be influenced by differences in cognitive ability. 
 Similar to the experiment by Holter et al., baseline differences in the acquisition 
of an operant conditioning procedure were observed in CB1 -/- mice trained to nose-poke 
for either corn oil or the sweetened reinforcer Ensure (Ward and Dykstra, 2005; Ward et 
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al., 2007).  Under either condition of reinforcement, both genotypes exhibited the ability 
to acquire the task.  However, regardless of the reinforcer used, fewer CB1 -/- mice 
achieved maximal responding than their wild-type counterparts. Higher levels of 
responding (e.g. active nose-poke hole responding) were observed during maintenance 
sessions in wild-type mice compared to CB1 -/- mice trained to respond for Ensure, and 
substitution of sweetened reward for the fat-reinforcer corn oil produced a similar 
decrease in responding.  As CB1 -/- mice primarily exhibited differences in responding, 
rather than the acquisition of the task, the hedonic value of the different appetitive 
rewards may account for observed genotype differences.  
 Results from the aversively conditioned Morris water maze spatial memory task 
suggest acquisition differences between genotypes result from differences in procedure, 
as genetic deletion of the CB1 receptor leaves spatial memory intact (Varvel and 
Lichtman, 2002).  Following repeated acquisition trials, the subject learns to use spatial 
cues surrounding the maze to locate and swim to a hidden platform.  In a fixed platform 
protocol, where the location of the hidden platform is constant, both genotypes exhibited 
similar latencies, as well as path lengths, to discover the target location.  While both 
genotypes displayed a similar overall reduction in thigmotaxia by the end of acquisition 
training, the decrease occurred more gradually in knockout mice than in wild-type mice.  
The possibility of an anxiogenic phenotype was further supported by the observation that 
one-half of the CB1 -/- mice stopped swimming in favor of floating, in some cases 
requiring rescue to prevent sinking.  Working memory was also assessed by shifting the 
platform to a new location each acquisition day.  Again, both genotypes showed similar 
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ability to acquire the task, however notable phenotypic differences were observed.  CB1 -
/- mice performed with a pronounced inconsistency, resulting in the removal of 50% of 
the subjects for failing to reach criteria. In extreme cases, seizures, and eventual death, 
occurred in five of the mice.  Furthermore, the authors reported reduced body weights, 
labored swimming, and dysfunctional search strategies (i.e., swimming in circles).  
Importantly, the observed differences were absent in wild-type mice.  
 In a follow-up experiment by the same group, CB1 -/- showed no differences in 
acquiring a fixed-platform task compared to wild-types (Varvel et al., 2005).  While the 
authors did not report genotype differences in thigmotaxia, alternative evidence for an 
anxiogenic phenotype was reported when non-contingent swimming was assessed.  In 
this experiment, naive subjects were exposed to the maze in the absence of an escape 
platform during massed probe trials.  Across trials, a gradual reduction in swim speed 
was observed in wild-type, but not CB1 -/- mice.  Thus, it would appear that while spatial 
memory is intact, differences in experimental design may produce cognitively unrelated 
effects arising from a possible anxiogenic phenotype. 
 
 
 
 
 
FAAH -/- MICE 
 
 
 
 
The recent genesis of mice lacking the gene for the FAAH enzyme provides a 
useful model for studying enhanced eCB signaling by inhibiting the metabolism of 
anandamide (Cravatt et al., 2001).   Varvel et al., (2006) were the first to report 
acquisition differences in FAAH -/- mice, compared to their wild-type controls in the 
Morris water maze spatial memory task.  During acquisition of a fixed platform 
procedure, both genotypes exhibited similar acquisition profiles, measured by escape 
latency, and the corresponding path length.  Conversely, in a working memory paradigm 
where the location of the hidden platform was placed in a new location each day, FAAH -
/- mice acquired the task significantly faster than their wild-type littermates.  Of interest, 
the authors note a non-significant trend (p=.06) of enhanced acquisition within the first 
acquisition day.   
In a follow-up experiment by the same group, FAAH -/- mice exhibited enhanced 
acquisition of a fixed-platform task (Varvel et al., 2007).  As these data are in contrast to 
results from the previous experiment, procedural differences may have accounted for the 
disparate nature of the results.  In the previous experiment, the hidden platform was 
placed arbitrarily towards the front of the tank (i.e. closest to the entrance to the 
enclosure).  Conversely, the current experiment placed the hidden platform in the back of 
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the tank (i.e. furthest from the entrance to the enclosure).  Apparently, wild type mice 
display a steeper acquisition curve when the platform is placed in the front aspect of the 
tank than in the back of the tank.  Thus, placing the hidden platform in the back of the 
tank unmasked phenotypic differences.   
 
 
 
 
RIMONABANT AND EXTINCTION LEARNING 
 
 
Extinction is the suppression of a previously learned behavior, following non-
reinforced trials.  Disruption of CB1 receptor signaling has been shown to impair 
extinction learning in aversively reinforced models of conditioned freezing (Marsicano et 
al., 2002; Suzuki et al., 2004; Niyuhire et al., 2007), passive avoidance (Niyuhire et al., 
2007), and spatial memory (Varvel et al., 2005).  In the cued conditioned fear paradigm, 
a subject learns that a tone is predictive of an impending footshock.   With each 
successive tone presentation in the absence of a footshock, the percentage of time spent 
immobile decreases, demarcating the occurrence of extinction learning.  Marsicano et al., 
(2002) were the first to show that administration of rimonabant prior to extinction trials 
resulted in a perseverance of freezing behavior, while vehicle treated subjects exhibited a 
gradual reduction in freezing behavior following repeated extinction trials.   Similarly, in 
the Morris water maze spatial memory task, mice learn to swim to a hidden platform 
during acquisition trials.  Following removal of the platform during extinction trials, 
subjects gradually decrease the amount of time spent in the quadrant that previously 
contained the hidden platform.  Thus, while vehicle-treated mice increasingly search 
other areas of the maze across extinction trials, rimonabant treated animals continue to 
perseverate in the irrelevant quadrant (Varvel et al., 2005).    Interestingly, in the water 
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maze, the disruption of extinction was only seen when weekly, but not massed (multiple 
probes separated by a short temporal delay), extinction trials were administered, 
suggesting temporal components of the task may be critical.  Finally, in the passive 
avoidance paradigm subjects learn to associate shock with one of two chambers.  
Following conditioning, daily extinction trials are administered and the latency to enter 
the chamber associated with shock is recorded.  In vehicle-treated animals, subjects 
exhibited a gradual reduction in the latency to enter the chamber associated with shock 
across extinction sessions.  Conversely, subjects administered rimonabant exhibited 
consistently elevated latencies across trials (Niyuhire et al., 2007).  
There is evidence that rimonabant does not affect extinction learning in 
appetitively reinforced tasks.  For example, rimonabant administration did not affect 
extinction of operant conditioning, either in daily or weekly trials (Niyuhire et al., 2007).  
Importantly, the results by Niyuhire et al., (2007) are in agreement with a previous 
operant conditioning study using CB1 -/- mice trained to nose poke for food reward 
(Holter et al., 2005).    Collectively, these results support the hypothesis that the nature of 
the reinforcer (e.g. aversive vs. appetitive) is primarily responsible for the expression of 
disrupted extinction in models of attenuated CB1 receptor signaling (Holter et al., 2005).   
 
 
 
 
 
SUMMARY 
 
 
 
 
An underlying theme in the review presented above is the inherent difficulty in 
comparing results from qualitatively different behavioral tasks.   As the models discussed 
in the review fluctuate primarily on either the source of reinforcement (i.e. appetitive vs. 
aversive), or behavioral demands (i.e. learning to lever-press or find a hidden goal), the 
necessity for a paradigm in which either is controlled is apparent.  The recent adaptation 
of the Barnes maze for use in mice presents the unique possibility of using dissimilar 
sources of reinforcement to motivate learning the same goal.  If validated, utilization of a 
modified Barnes maze would facilitate addressing three outstanding questions in the 
literature. 
First, the specific conditions in which rimonabant affects extinction learning have 
yet to be determined, but appear to depend on whether the behavior is learned in an 
appetitive or aversive task (Holter et al., 2005; Niyuhire et al., 2007).   However, there 
are two outstanding issues with the latter hypothesis.  First, rimonabant may produce a 
decrease in hedonic value of the reward used in both studies (food pellet or sweetened 
milk).  Previous research has shown that rimonabant, and CB1 receptor deletion, 
decreases food consumption (Kirkham and Williams, 2001), salience of food reward 
(Ward and Dykstra, 2005), and preference for sweetened foods (Arnone et al., 1997; 
 30 
31 
 
Higgs et al., 2003).  Predictably, CB1 -/- mice required a greater level of food restriction 
to reach asymptotic acquisition performance as wild-type littermates (Holter et al., 2005).  
Again, the difficult nature of resolving differences in hedonics (i.e. aversive vs. 
appetitive) and the disparate behavioral demands of the tasks preclude interpretation.   
Second, many reports suggest genetic deletion of the CB1 receptor affects 
acquisition learning.   However, conflicting reports exist regarding how acquisition is 
affected (i.e. facilitated, impaired, or unaffected), and under what reinforcement 
conditions.  For example, CB1 -/- mice have exhibited a broad spectrum of acquisition 
effects in aversively reinforced paradigms.  Genetic disruption of CB1 receptor signaling 
enhances acquisition of an active avoidance paradigm (Martin et al., 2002); impairs 
learning of contextual conditioned fear sometimes (Mikics et al., 2006), but not always 
(Suzuki et al., 2004), and delay eyeblink conditioning (Kishimoto and Kano, 2006); but 
does not affect spatial memory (Varvel and Lichtman, 2002; Varvel et al., 2005), cued 
conditioned fear (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006), or 
trace eyeblink conditioning (Kishimoto and Kano, 2006).   Appetitively reinforced 
models suggest acquisition is intact following CB1 receptor deletion.  Bilkei-Gorzo et al., 
(2005), were the first to report intact acquisition of an operant conditioning procedure in 
young (6-7 weeks of age) CB1 -/- mice compared to age-matched controls.  In agreement 
with these results, deficits in acquisition learning were not reported in operant 
conditioning experiments utilizing mature CB1 -/-  and +/+ mice trained to nose-poke for 
food pellets (Holter et al., 2005), Ensure (a sweetened protein drink), or corn-oil (Ward et 
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al 2007; Ward, personal communication, 2007).  An important caveat of these studies is 
the increased level of food deprivation in the knockout mice to increase their motivation 
to work for food reward.  Thus, similar acquisition profiles in a task where behavioral 
demands are constant, and only the source of reinforcement is variable, would suggest 
disparate acquisition performance in the literature result from procedural differences.  
Importantly, controlling for confounds associated with CB1 -/- mice, such as age and 
motivation for food reward, must be considered in future studies. 
Finally, there is a need for further research evaluating the cognitive impact of 
enhancing eCB signaling through FAAH inhibition.   The increased levels of brain 
anandamide in FAAH -/- mice is correlated with accelerated acquisition rates in both 
working (Varvel et al., 2006) and fixed-platform (Varvel et al., 2007) Morris water maze 
tasks.  As these reports represent the extent of the acquisition literature in FAAH -/- mice, 
and utilize inherently aversive procedures, it is unknown whether limitations exist in the 
expression of enhanced acquisition.  Thus, performance in the aforementioned modified 
Barnes maze provides an opportunity to determine if reinforcement conditions dictate the 
expression of enhanced acquisition in FAAH -/- mice.  
 
 
 
 
 
 
 
 
 
 
 
 
THE BARNES MAZE 
 
 
Carol Barnes developed the first working model of the Barnes maze (fig. 1) in 
1979 to study senescence in rats (Barnes, 1979).  She hypothesized that the advantage of 
this task is its superior control for different levels of stress between groups.  For example, 
many earlier tasks required a greater degree of food deprivation in older mice in an 
attempt to generate ‘equal’ levels of motivation (Goodrick, 1968).   Furthermore, motor 
confounds related to age might be avoided by using an easily traversed land maze that did 
not require more demanding motor performance such as with swimming.  In her words 
(personal communication): 
“I developed this task in the mid-1970s for old rats - the idea was to come 
up with a spatial memory task that didn't require shock, or food restriction 
- in those days, you had to "grow your own" old rats, and I wanted them to 
"want to participate" without risking health issues (if they died, there were 
no replacements).  This apparatus was the outcome - in its original 
incarnation we put females (the rats in the study were males) in a cage 
below the platform as extra incentive - but this turned out not to be 
necessary for good performance.  We also moved the platform to a huge 
room, because I noticed that the rats became more 'comfortable' staying 
out on the platform surface (even under bright lights) if the walls were 
close to the edge.” 
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area, thereby avoiding 
 in 
 
atic 
 
The Barnes maze 
utilizes natural sources of 
motivation such as the 
tendency to avoid bright 
lights and air turbulence in 
favor of an enclosed dark 
confounds relating to food deprivation, footshock, 
stress, and stamina during studies of senescence 
(Barnes, 1979).   Years after its initial development for 
rats, the maze was adapted for use in mice to evaluate 
transgenic CaMKII -/- (Bach et al., 1995).  In their 
short description, the authors reported an increase
the number, and reduction in the size, of the holes 
along the perimeter of the maze, as well as the 
inclusion of aversive stimuli (i.e. bright lights and a 
buzzer).   Fox et al., (1998) reported the first detailed
description of the adapted maze to evaluate traum
brain injury (fig. 2).  However, little credit has been 
given to both Fox et al., and Bach et al., for being the
first to adapt the Barnes maze for use in mice.  
Figure 2: The Barnes maze for mice 
(Fox et al., 1998) 
Figure 1: The Barnes Maze (Barnes, 1979) 
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The current absence of an established 
Barnes maze apparatus/procedure appears related 
to the development of ‘pseudo-Barnes mazes,’ 
and begins with a report by Pompl et al., (1999).  
In this study, the investigators utilized a 
‘downsized circular platform’ (fig. 3) to evaluate 
the cognitive performance of APPsw-/- mice.  
Departing from the traditional, unenclosed open 
field, the perimeter of the maze contained a 
second set of cues.  In their report, the authors extend 
on the advantages (vs. the Morris water maze) listed 
by Barnes (1979), adding that extensive pre-training is unnecessary, there is a minimal 
reliance on sensorimotor skills, fewer required testing days than other spatial memory 
tasks, and an inability for mice to use odor cues or exact motor sequences to solve the 
task.  Furthermore, they were the first to report the Barnes maze as less stressful than the 
Morris water maze, an unsubstantiated claim that spread through the literature for years 
thereafter.  In their defense, there remains evidence that the stress induced by other 
spatial memory models may affect results.  For example, water temperature in the Morris 
water maze can affect performance in a glucocorticoid dependent manner (Sandi et al., 
1997; Sandi, 1998).  However, no work exists comparing these two spatial memory 
paradigms directly (Harrison et al., 2006).   
Figure 1:The Barnes maze (Pompl et al., 
1999) 
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While only a handful of reports have been published using the adapted Barnes 
maze for mice, most have relied on similar sources of reinforcement.  For example, many 
reports utilize escape from aversive stimuli, such as bright lights (Bach et al., 1995; Fox 
et al., 1998; Pompl et al., 1999; Inman-Wood et al., 2000; Williams et al., 2003; Bredy et 
al., 2004), air turbulence (Pompl et al., 1999; Inman-Wood et al., 2000) rock and techno 
music (Fabricius et al., 2008), and tones (Bach et al., 1995; Pompl et al., 1999; Inman-
Wood et al., 2000; Bredy et al., 2004).  Alternatively, some authors report the use of 
appetitive (i.e. food reward) reinforcement (Grootendorst et al., 2001; Williams et al., 
2003).   Moreover, some reports have suggested the return to the home cage, as well as 
gentle handling (Harrison et al., 2006), are the primary source of reinforcement (Blizard 
et al., 2003; Williams et al., 2003).  Unlike other spatial memory tasks, the Barnes maze 
is unique as it allows different sources of motivation (i.e. aversive vs. appetitive) to drive 
the same behavior (e.g. entering the goal box) [for a summary of the literature, see 
appendix A].   
In the following dissertation, we capitalized on the unique nature of the Barnes 
maze by comparing acquisition and extinction learning utilizing disparate sources of 
reinforcement.  Specifically, bright lights and air turbulence motivated learning under 
aversive conditions (fig. 4 and 5), and access to water motivated learning under appetitive 
conditions (fig. 6).  Unlike previous publications, we chose to depart from sweetened 
food reward under appetitive conditions in favor of water reward.  As the present study 
focuses on manipulations to the endocannabinoid system, water reward circumvented 
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possible confounds related to appetite and hedonic value.  Importantly, rimonabant has 
been shown to leave water consumption unaffected (Arnone et al., 1997) at moderate 
doses (Colombo et al., 1998). To our knowledge, this is the first report to use access to 
water to motivate learning in the Barnes maze task.
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Figure 4: The Barnes maze (Harloe, 2007) 
Figure 5: Unmodified goal box for aversive reinforcement conditions. 
Figure 6: Goal box following modification for appetitive reinforcement conditions. 
 
 
 
 
 
EXPERIMENT 1 
 
 
 
 
INTRODUCTION 
 
     
The environmental conditions necessary to observe disrupted extinction learning 
following rimonabant administration are uncertain, but appear dependent on the source of 
reinforcement.  For example, rimonabant disrupts extinction in aversive conditioning 
paradigms such as the Morris water maze, conditioned fear, and passive avoidance, but 
not in appetitively reinforced operant conditioning procedures (Marsicano et al., 2002; 
Holter et al., 2005; Varvel et al., 2005; Niyuhire et al., 2007).  It is difficult to reconcile 
between the qualitative hedonic value of the reinforcer (i.e., eliciting appetitively-
motivated versus aversively motivated behavior) and the disparate behavioral demands of 
differing tasks.  Thus, in order to discern whether the hedonic value of the reinforcer 
plays a determining role in the outcome of dissimilar behavioral models, it is critical to 
utilize a paradigm in which the nature of the reinforcement is varied but the behavioral 
demands of the task remain constant.  A unique aspect of the Barnes maze is that 
different sources of reinforcement can be utilized to drive the same behavior (i.e., finding 
and entering the goal box) to escape aversive stimuli or obtain appetitive reinforcement.  
Here, we utilized bright lights and air turbulence to motivate learning under aversive 
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conditions and access to drinking water under appetitive conditions.  As future studies 
will focus on the endocannabinoid system, water reward circumvented confounds related 
to the observations that genetic disruption or pharmacological inhibition of the CB1 
receptor often reduces operant responding for and the intake of palatable food (De Vry 
and Jentzsch, 2004; Holter et al., 2005; Ward and Dykstra, 2005), though not always 
(Jarrett et al., 2005).  Importantly, compromising CB1 receptor signaling has been shown 
to leave water consumption unaffected at moderate doses (Arnone et al., 1997; Colombo 
et al., 1998).  To the best of our knowledge, the studies presented in this dissertation are 
the first to use access to drinking water to motivate learning in the Barnes maze task. 
The initial objective of the present study was to characterize aversively- and 
appetitively conditioned acquisition and extinction learning in the Barnes maze.  
Moreover, these experiments allowed us to test the hypothesis that mice will exhibit 
acquisition and extinction learning during both and appetitively and aversively motivated 
Barnes maze task.  In addition, a third group of subjects was assessed under conditions 
common to both the aversive and appetitive procedures.  In this control group, no bright 
lights, air turbulence, water access, or water deprivation were used.  Finally, a control 
experiment was performed to differentiate between extinction learning and the gradual 
decay of memory, or forgetting.  In subsequent experiments, manipulations of the 
endogenous cannabinoid system were evaluated in these appetitive and aversive tasks.
 
 
 
 
 
METHODS 
 
 
 
SUBJECTS 
 
 
A total of 79 C57BL/6J (Jackson Labs, Bar Harbor, ME) mice, weighing between 
20-30 g, and housed individually, were used as subjects.  All subjects were housed in a 
temperature-controlled (20-22º C) environment, with a 12-h light/dark cycle and ad 
libitum access to food. Mice in the ambient (n=8) or aversive condition (n=35) were 
allowed ad libitum access to water in their home-cage for the entirety of the study, while 
mice in the appetitive condition (n=36) were only given access to water for 2 h per day 
(see procedure below).  All experiments have been approved by the Institutional Animal 
Care and Use Committee at Virginia Commonwealth University.   
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APPARATUS 
 
 
 
 
The Barnes maze (Hamilton-Kinder, Poway, CA) consisted of a round board (122 
cm diameter) fabricated from PVC with 40 holes (2.54 cm diameter) surrounding the 
perimeter of the maze.  The maze was divided into six zones, each containing a possible 
location for the goal box (19.5 cm X 5.5 cm).  A square 152 cm X 152 cm aluminum 
frame enclosure surrounded the apparatus and was used to hang contextual cues (i.e. 
various dark shapes) on white curtains that encircled the maze.  A circular starting tube 
(7.62 cm. internal diameter) was placed in the center of the maze to ensure that all 
subjects began each trial from the same location.  The tube was attached to a cord and 
pulley system, which the investigator could raise from outside the enclosure.  The trial 
began 3 s after the subject was placed in the starting tube.  A digital camera (Panasonic 
BP-330), connected to a nearby computer running AnyMaze software (Stoelting, Wood 
Dale, IL), allowed the observer to watch and record without disturbing the subject.  Both 
the maze and goal box were wiped with an ammonia based cleaner (Whistle 
[JohnsonDiversey Inc., Sturtevant, WI]) after each trial. 
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PROCEDURE 
 
 
 
 
Three types of testing conditions were used: aversive, ambient, and appetitive.  In 
the aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide 
fans (Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and 
remained on during all stages and trials.  In the appetitive procedure, a modified goal box 
containing access to water was used as a reinforcer for water-deprived mice. Subjects 
were given 22 h of daily water deprivation before each session and were weighed for 
comparison to a pre-deprivation baseline.  Immediately after each session, the mice were 
returned to their home cages, given access to water for 2 h, and weighed.  Finally, in the 
ambient condition, stimuli were limited to those inherent to the laboratory environment 
(e.g. fluorescent lighting) and the Barnes maze apparatus (e.g. entering the goal box) 
during appetitive and aversive procedures.   No additional stimuli or water restriction 
were introduced. 
 
Shaping 
 
All subjects were acclimated to the apparatus and basic procedure before formal 
acquisition training began.  The subject was placed in the start cylinder and was released 
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once the experimenter had closed the curtain and initiated the software.  Three min later, 
the subject was placed in the goal box, which was then slid into one of the six 
corresponding target locations.  A metal lid was placed over the escape hole to prevent 
the mouse from exiting.  Following two min of acclimation to the goal box, the mouse 
was placed into its home cage for a 30 s intertrial interval (ITI).  After the ITI, the goal 
box was placed back into its corresponding location and the subject was guided from the 
center of the maze to the entrance of the goal box.  Shaping was concluded after at least 
two consecutive entries into the goal box without provocation from the investigator.  
 
Acquisition 
 
Each mouse was given four acquisition trials per day for ten days.  Each trial 
ended when either three min had elapsed or the subject entered the goal box, whichever 
occurred first.  In the event that the mouse failed to enter the goal box within the three 
min trial, it was placed in the center of the maze and the experimenter led it to the goal 
box where it remained for 30 s before being returned to its home cage for the 30 s ITI.  If 
the mouse repeatedly found the goal box, but failed to enter, it was given additional 
shaping in which it was again placed in the center of the maze and led to the escape hole, 
a process that was repeated until the mouse entered the goal box without provocation 
from the experimenter.  Acquisition measures included test duration (latency to enter the 
hidden goal box), total time spent immobile, distance traveled, and adjusted speed. 
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Extinction  
 
In order to assess extinction, the goal box was removed and subjects were given a 
single, three-min probe trial per day for a total of 10 days.  Extinction was inferred to 
have occurred when the percentage of time spent in the target zone was significantly 
reduced compared to the first probe trial or to chance levels (18%).  Additionally, as with 
acquisition, total time immobile, adjusted speed and distance traveled were analyzed to 
assess locomotor effects. 
To differentiate between forgetting and extinction, the mice were given 10 days of 
acquisition training in either aversive (n=15) or appetitive (n=17) conditions, as described 
above, and were then divided into two separate groups.  The first group received 10 days 
of extinction training.  The second group remained in the vivarium during the first nine 
days of extinction.  On the tenth day after acquisition, this group was given a 3 min probe 
trial to assess whether they still recalled the location of the hidden escape hole.   
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STATISTICAL ANALYSES 
 
 
 
 
AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate most of 
the dependent measures of interest.  The maze was divided into six zones to determine 
the duration of time spent in the target zone (the zone that contained the goal box).  Other 
dependent measures of interest included adjusted speed (distance traveled/(latency to 
enter – time immobile)), distance traveled, time spent immobile, and latency to enter the 
goal box (test duration).  
Results from comparison studies were analyzed using two-way mixed design 
ANOVAs (treatment by session).  A significant effect of motivating condition was 
further analyzed for each condition by a one-way repeated measures ANOVA.  Dunnett’s 
post-hoc analysis with comparison to day one values was used when appropriate.  
Significant interactions were analyzed in the same manner, but also included comparison 
of reinforcing condition within each acquisition or extinction session using the Tukey 
post-hoc test.   Finally, a student’s t-test was used to distinguish between forgetting and 
extinction.  The accepted level of significance for the tests was p<0.05.   
 
 
 
 
 
RESULTS 
 
 
 
 
Acquisition of aversive, appetitive, and ambient conditioning groups 
 
 
Figure 7A-D illustrates each of the dependent measures for acquisition in the 
aversive, appetitive, and ambient conditions.  A significant effect of acquisition day was 
found for all dependent measures including distance [fig. 7A; F(9,396)=25.0, p<0.0001], 
latency to enter [fig. 7B; F(9,396)=52.0, p<0.0001], adjusted speed [fig. 7C, 
F(9,396)=26.0, p<0.0001], and time immobile [fig. 7D; F(9,396)=7.7, p<0.0001]. 
While subjects learned the task in each condition, differences in acquisition rates, 
as well as locomotor effects, were detected.  Specifically, a significant effect of 
conditioning procedure was found for latency to enter [F(2, 396)=15.0, p<0.0001], 
distance traveled [F(2,396)=6.4, p<0.01], time immobile [F(2,396)=9.9, p<0.001], and 
adjusted speed [F(2,396)=8.2, p<0.001].  In each situation, no differences were found 
between the aversive and appetitive conditioning group, but both were significantly 
different from the ambient condition.  
Significant interactions between conditioning procedure and acquisition day were 
found for adjusted speed [F(18,396)=2.1, p<0.01] and time immobile [F(18,396)=3.5, 
p<0.0001].  While subjects in the aversive and appetitive condition reached asymptotic 
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performance based on latency to enter the hidden goal box, subjects under the ambient 
condition showed significantly longer latencies to enter the goal box than the other two 
groups.  Additionally, subjects in the ambient condition showed no change in the amount 
of time spent immobile [F(9,63)=1.5, p=0.1] over the 10 acquisition days.  When speed 
was adjusted to account for time spent immobile, all groups showed a gradual increase in 
running speed over acquisition days (appetitive [F(9,162)=14.0, p<0.0001]; aversive 
[F(9,171)=22.7, p<0.0001]; ambient [F(9,63)=3.8, p<0.001]).  
Finally, water restricted subjects were weighed twice daily to investigate whether 
they would be able to maintain a proper range of body weight following water-
deprivation.  While subjects showed an initial drop in body weight, they quickly adjusted 
to the schedule, never falling below 75% of their baseline weight (fig. 8).  No apparent 
differences in water consumption were observed, however considerable leakage from the 
water bottle prevented accurate measurement.   
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Figure 7: Mice learn to enter a hidden goal box in the Barnes maze under aversive, 
appetitive, and ambient conditioning procedures.  Panel A. Distance traveled to enter 
the box (cm). Panel B. latency to enter the goal box.  Panel C. Adjusted running speed 
(cm/s) was determined by the following formula: [distance/(latency to enter – time 
immobile)].  Panel D. average time spent immobile.  The data for each session 
represent the average of four daily trials ± SEM.  # p<0.05 ## p<0.01 # vs. the 
appetitive condition.  $ p<0.05 $$ p<0.01 vs. aversive condition.     p<0.05  
p<0.01  vs. ambient reinforcement.  N=8-20 mice/group.  The data for each session 
represent the average of four daily trials ± SEM.  N=8-20 mice/group. 
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Figure 8:  Mice rapidly adapt to water deprivation.   Average daily weight (g) recorded 
before and after 2-h access to water following 22-h of deprivation.   ---------  indicates 
average baseline weight prior to testing and the shaded error represents the standard 
error of baseline weight.   All data are represented as mean ± SEM.  N=10. 
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Extinction of aversive, appetitive, and ambient conditioning groups 
 
 
 
Significant reductions in the percentage of time spent in the target zone across the ten 
probe trials in the aversive conditioning procedure [fig. 9A; F(9,63)=6.4, p<0.05], the 
appetitive conditioning procedure [fig. 9C; F(9,36)=3.5, p<0.01], and under ambient 
conditions [fig. 9E; F(9,63)=4.4, p<0.001].  Additionally, the mice displayed a significant 
decrease in adjusted speed across extinction trials in the aversive [fig. 9B; F(9,63)=9.3, 
p<0.0001] and ambient [fig. 9D; F(9,63)=2.1, p<0.05], but not appetitive (fig. 9F; 
p=0.51) condition.   These results indicate that a 3 min daily extinction trial is sufficient 
to produce extinction learning. 
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Figure 9: Exposure to the Barnes maze after removal of the goal box leads to 
extinction.  Mice were given ten day of acquisition training in aversive (top panels), 
appetitive (middle panels), or ambient (bottom panels) conditioning procedures.  The 
percentages of time spent in the target zone (i.e., the area formerly associated with the 
goal box) are shown for each condition (panels A, C, and E).  The dotted line from the 
18% point of the ordinate spanning to the width of the abscissa indicates chance 
performance.  Adjusted speeds [distance/(latency to enter – total time immobile)] are 
represented for aversive (panel B), appetitive (panel D), and ambient (panel F) 
conditions.  * p<0.05 ** p<0.01 vs. extinction day 1 values.  ------- Represents chance 
performance.  All data are represented as mean ± SEM.  N=5-8 mice/group. 
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Forgetting vs. extinction 
 
 
 
 
In order to distinguish between extinction learning and forgetting, naive mice 
were given 10 days of acquisition training in either the aversive conditioning procedure 
or the appetitive conditioning procedure.  The mice in each conditioning procedure were 
divided into two groups, with the first group receiving a daily extinction trial for 10 days 
(Group Extinction) and the second group (Group No Extinction) receiving only a single 
probe trial that coincided with extinction day 10 for Group Extinction.  As can be seen in 
fig. 10A, Group Extinction in the aversive conditioning procedure displayed a significant 
decrease in the percentage of time spent in the target zone across the ten probe trials, 
[F(9,54)=2.8, p<0.01].  In contrast, Group No Extinction, which was given a single probe 
trial ten days after acquisition, spent significantly more time in the target zone than 
Group Extinction [t(13)=3.0, p<0.01].  Moreover, no differences were observed when 
comparing the percentage of time spent in the target zone between the single probe trial 
of Group No Extinction and the first extinction trial of Group Extinction [t(13)=.1, 
p=0.93]). 
A similar pattern of results was found when appetitive conditions were employed.  
Again, Group Extinction showed a significant decrease in the percentage of time spent in 
the target zone across the ten probe trials [fig. 10B, F(9,81)=4.1, p<0.001].  Group No 
Extinction appeared to remember the location of the target box ten days after acquisition, 
as they spent a similar amount in the target zone as Group Extinction on their first 
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extinction trial [t(15)=1.1, p=0.26].  Additionally, Group No extinction spent a 
significantly greater percentage of time in the target area compared to Group Extinction’s 
tenth trial [t(15)=4.9, p<0.001].  Thus, under both aversive and appetitive conditions, 
subjects still recall the location of the escape box ten days after training.  However, daily 
three min exposures to the Barnes maze with no goal box present were sufficient to elicit 
extinction under both conditioning regimens. 
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Figure 10: Extinction learning is independent of forgetting.  Percentage of time 
spent in the target zone (i.e., the zone previously containing the escape box) during 
extinction of an aversively (panel A) and appetitively (panel B) conditioned Barnes 
maze tasks.  All subjects were given ten days of acquisition training, as described in 
the methods.  Following acquisition, subjects in Group Extinction were given ten 
daily three min exposures to Barnes maze, but the goal box was removed.  Group 
No Extinction received a single three min trial in the Barnes maze without the goal 
box that coinciding with extinction day 10 for Group Extinction.  The dotted line 
from the 18% point of the ordinate spanning to the width of the abscissa indicates 
chance performance.  *p< 0.05; **p<0.01 vs. Group Extinction.  All data are 
represented as mean ± SEM.  N=7-10 mice/group. 
 
 
 
 
DISCUSSION 
 
 
While our lab has previously employed the Morris water maze to evaluate the role 
of the endogenous cannabinoid system on extinction, this task is inherently aversive 
(Morris, 1984).  This notion is supported by the observation that water maze training 
activates the pituitary adrenal axis, causing an increase in corticosterone (Sandi et al., 
1997; Akirav et al., 2001).  Rimonabant disrupted extinction learning in the Morris water 
maze (Varvel et al., 2005), as well as other aversively conditioned paradigms such as 
passive avoidance and conditioned fear (Marsicano et al., 2002; Niyuhire et al., 2007).  
Conversely, rimonabant does not affect extinction learning in appetitively conditioned 
operant tasks (Holter et al., 2005; Niyuhire et al., 2007).  In contrast, the Barnes maze 
spatial memory paradigm presented a unique opportunity of comparing different sources 
of reinforcement, either aversive or appetitive (i.e. food and entering the goal box), to 
motivate the same goal.  Only a handful of published reports have employed the Barnes 
maze to evaluate mice and most of this work has relied on similar sources of aversive 
reinforcement, such as bright lights, air turbulence, or auditory stimuli (Bach et al., 1995; 
Fox et al., 1998; Pompl et al., 1999; Inman-Wood et al., 2000; Williams et al., 2003; 
Bredy et al., 2004).  Conversely, other studies have utilized positive reinforcement, such 
as food, gentle handling, or the return to the home cage to motivate Barnes maze learning 
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(Grootendorst et al., 2001; Blizard et al., 2003; Koopmans et al., 2003; Williams et al., 
2003; Harrison et al., 2006).   
To focus on the qualitative nature of the reinforcer, we modified the Barnes maze 
task in the present study to evaluate appetitively and aversively motivated conditioning 
procedures on acquisition and extinction, but required the same motor responses (i.e., 
searching and entering the goal box).  Subjects acquired the Barnes maze task 
irrespective of reinforcement condition, illustrated by significant reductions in both path 
length and test duration across acquisition days.  Removal of the goal box following 
acquisition trials produced a gradual decrease in the percentage of time spent in the target 
zone for all conditions, indicating the occurrence of extinction learning.  Importantly, 
control experiments demonstrated extinction learning was independent of forgetting, 
under both appetitive and aversive conditions.   Collectively, the results support the 
utilization of this model as a viable method of assessing spatial memory in a paradigm in 
which the nature of reinforcement is variable, but the behavioral demands of the task 
remain constant.  
The Barnes maze is traditionally used to assess spatial memory, requiring the 
subject to use spatial cues to find a hidden location (Bach et al., 1995).  It has been 
reported that animals progress through random, serial, and direct search strategies during 
acquisition of the Barnes maze task (Barnes, 1979).  While we initially attempted to 
record these three search strategies, we elected not to use this measure.  There is 
difficulty in objectively scoring these strategies because subjects often, in no particular 
order, utilize all three strategies within a single acquisition day, though by the completion 
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of acquisition training, nearly every subject adopted the direct strategy.  Accordingly, we 
elected to rely on path length and latency to enter the hidden goal box measures to infer 
learning and percentage of time spent in the target zone to infer extinction learning.  
Results garnered from the ambient condition indicate that mice placed on the 
Barnes maze, without any extra environmental manipulations (e.g., bright lights, air 
turbulence, or access to water) will learn to enter the hidden box, though they do not enter 
the goal box as quickly as mice in the aversive or appetitive conditioning procedures, 
suggesting environmental manipulations increased acquisition rates.  Additionally, when 
the hidden goal box was removed, the mice in the ambient condition extinguished 
searching in the target zone at a similar rate as the mice in the other two groups.  Thus, 
mere placement onto the Barnes maze is a sufficient motivator for mice to learn to find 
and enter the goal box.  The finding that the mice prefer the goal box to remaining on the 
open maze is not surprising given that open fields generally provoke anxiety-like states in 
rodents (Crawley, 1985).     
 
 
 
 
 
EXPERIMENT 2 
 
 
 
 
INTRODUCTION 
 
A growing body of literature has implicated the eCB system in extinction learning 
in which learned behavior becomes suppressed when reinforcement is withheld.  
Disruption of CB1 receptor signaling, through either its genetic deletion or administration 
of a receptor antagonist impairs extinction learning in a variety of aversively motivated 
tasks, including conditioned freezing (Marsicano et al., 2002; Suzuki et al., 2004; 
Kamprath et al., 2006; Niyuhire et al., 2007), passive avoidance (Niyuhire et al., 2007), 
and the Morris water maze spatial memory task (Varvel et al., 2005).  A common aspect 
of these tasks is that each uses an aversive unconditioned stimulus.  In contrast, 
disruption of CB1 receptor signaling failed to affect extinction learning in operant 
conditioning tasks that use palatable food as the reinforcer (Holter et al., 2005; Niyuhire 
et al., 2007; Ward et al., 2007).  Specifically, CB1 -/- mice displayed similar rates of 
extinction as wild type mice in nose-poking tasks for food pellets (Holter et al., 2005) as 
well as for EnsureR (a sweetened protein drink) or corn oil (Ward et al., 2007).  To 
account for the differential consequences of CB1 deletion on extinction learning in 
operant and other behavioral paradigms, Holter et al (2005) hypothesized that the eCB 
system plays an important role in extinction of aversively-motivated learned behavior, 
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but is dispensable for the extinction of appetitively-motivated behavior.  Similarly, 
rimonabant treatment failed to affect extinction rates in a lever pressing operant task for 
sweetened condensed milk (Niyuhire et al., 2007), providing pharmacological evidence 
the CB1 receptor does not play a role in extinction of appetitively-motivated behavior.   
It is difficult to reconcile between the qualitative hedonic value of the reinforcer 
(i.e., eliciting appetitively-motivated versus aversively motivated behavior) and the 
disparate behavioral demands of differing tasks.  Thus, in order to discern whether the 
hedonic value of the reinforcer plays a determining role in the activation of the 
endogenous cannabinoid system, it is critical to utilize a behavioral paradigm in which 
the nature of the reinforcement is varied but the behavioral demands of the task remain 
constant.  In the present study, we used modified versions of the Barnes maze (Barnes, 
1979), characterized and evaluated in the previous chapter,  to examine the consequences 
of pharmacologically blocking endocannabinoid signaling on extinction learning in mice.  
A unique aspect of the Barnes maze is that different sources of reinforcement can be 
utilized to drive the same behavior (i.e., finding and entering the goal box) to escape 
aversive stimuli or obtain appetitive reinforcement.  Here, we utilized bright lights and air 
turbulence to motivate learning under aversive conditions and access to drinking water 
under appetitive conditions.  As the present study focuses on manipulations to the 
endocannabinoid system, water reward circumvented confounds related to the 
observations that genetic disruption or pharmacological inhibition of the CB1 receptor 
often reduces operant responding for and the intake of palatable food (De Vry and 
Jentzsch, 2004; Holter et al., 2005; Ward and Dykstra, 2005), though not always (Jarrett 
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et al., 2005).  Importantly, compromising CB1 receptor signaling has been shown to leave 
water consumption unaffected at moderate doses (Arnone et al., 1997; Colombo et al., 
1998).  
The primary objective of this study was to test the hypothesis that the endogenous 
cannabinoid system plays a differential role in modulating extinction in aversive and 
appetitive conditioning paradigms.  While the behavioral demands (i.e., locating and 
entering the escape box) for conditioning was kept constant, the qualitative value of the 
reinforcement was experimentally manipulated.  In the present study, we evaluated the 
effects of rimonabant administration in appetitive and aversive Barnes maze tasks.  
Accordingly, we sought to determine the outstanding question of whether observed 
differences of rimonabant on extinction learning were due to hedonics or the disparate 
nature of the tasks utilized.     
 
 
 
 
 
 
 
METHODS 
 
SUBJECTS 
 
A total of 71 C57BL/6J (Jackson Labs, Bar Harbor, ME) mice, weighing between 
20-30 g, and housed individually, were used as subjects.  All subjects were housed in a 
temperature-controlled (20-22º C) environment, with a 12-h light/dark cycle and ad 
libitum access to food.  Mice in the aversive condition (n=53) were allowed ad libitum 
access to water in their home-cage for the entirety of the study, while mice in the 
appetitive condition (n=18) were only given access to water for 2 h per day (see 
procedure below).  All experiments have been approved by the Institutional Animal Care 
and Use Committee at Virginia Commonwealth University.   
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DRUGS 
 
Rimonabant (SR-141716A) was obtained from the National Institute on Drug 
Abuse (Rockville, MD).  The drug was dissolved into a vehicle consisting of ethanol, 
alkamuls-620 (Rhone-Poulenc, Princeton, NJ), and saline at a ratio of 1:1:18, and a 3 
mg/kg dose was administered i.p. 30 min prior to testing at a volume of 10 ml/kg. 
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APPARATUS 
 
The Barnes maze (Hamilton-Kinder, Poway, CA) consisted of a round board (122 
cm diameter) fabricated from PVC with 40 holes (2.54 cm diameter) surrounding the 
perimeter of the maze.  The maze was divided into six zones, each containing a possible 
location for the goal box (19.5 cm X 5.5 cm).  A square 152 cm X 152 cm aluminum 
frame enclosure surrounded the apparatus and was used to hang contextual cues (i.e. 
various dark shapes) on white curtains that encircled the maze.  A circular starting tube 
(7.62 cm. internal diameter) was placed in the center of the maze to ensure that all 
subjects began each trial from the same location.  The tube was attached to a cord and 
pulley system, which the investigator could raise from outside the enclosure.  The trial 
began 3 s after the subject was placed in the starting tube.  A digital camera (Panasonic 
BP-330), connected to a nearby computer running AnyMaze software (Stoelting, Wood 
Dale, IL), allowed the observer to watch and record without disturbing the subject.  Both 
the maze and goal box were wiped with an ammonia based cleaner (Whistle 
[JohnsonDiversey Inc., Sturtevant, WI]) after each trial. 
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PROCEDURE 
 
Two types of testing conditions were used: aversive and appetitive.  In the 
aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide fans 
(Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and 
remained on during all stages and trials.  In the appetitive procedure, a modified goal box 
containing access to water was used as a reinforcer for water-deprived mice. Subjects 
were given 22 h of daily water deprivation before each session and were weighed for 
comparison to a pre-deprivation baseline.  Immediately after each session, the mice were 
returned to their home cages, given access to water for 2 h, and weighed. 
 
Shaping 
 
All subjects were acclimated to the apparatus and basic procedure before formal 
acquisition training began.  The subject was placed in the start cylinder and was released 
once the experimenter had closed the curtain and initiated the software.  Three min later, 
the subject was placed in the goal box, which was then slid into one of the six 
corresponding target locations.  A metal lid was placed over the escape hole to prevent 
the mouse from exiting.  Following two min of acclimation to the goal box, the mouse 
was placed into its home cage for a 30 s intertrial interval (ITI).  After the ITI, the goal 
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box was placed back into its corresponding location and the subject was guided from the 
center of the maze to the entrance of the goal box.  Shaping was concluded after at least 
two consecutive entries into the goal box without provocation from the investigator.  
 
Acquisition 
 
Each mouse was given four acquisition trials per day for ten days.  Each trial 
ended when either three min had elapsed or the subject entered the goal box, whichever 
occurred first.  In the event that the mouse failed to enter the goal box within the three 
min trial, it was placed in the center of the maze and the experimenter led it to the goal 
box where it remained for 30 s before being returned to its home cage for the 30 s ITI.  If 
the mouse repeatedly found the goal box, but failed to enter, it was given additional 
shaping in which it was again placed in the center of the maze and led to the escape hole, 
a process that was repeated until the mouse entered the goal box without provocation 
from the experimenter.  Acquisition measures included test duration (latency to enter the 
hidden goal box), total time spent immobile, distance traveled, and adjusted speed. 
 
Extinction  
 
In order to assess extinction, the goal box was removed and subjects were given a 
single, three-min probe trial per day for a total of 10 days.  Extinction was inferred to 
have occurred when the percentage of time spent in the target zone was significantly 
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reduced compared to the first probe trial or to chance levels (18%).  The latency to find 
the target hole, time spent immobile, and the number of nose pokes into the target hole 
were assessed during extinction.  Additionally, as with acquisition, adjusted speed and 
distance traveled were analyzed to assess locomotor effects. 
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STATISTICAL ANALYSES 
 
AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate most of 
the dependent measures of interest.  The maze was divided into six zones to determine 
the duration of time spent in the target zone (the zone that contained the goal box).  Other 
dependent measures of interest included adjusted speed (distance traveled/(latency to 
enter – time immobile)), distance traveled, time spent immobile, and latency to enter the 
goal box (test duration).  
Results from comparison studies were analyzed using two-way mixed design 
ANOVAs (treatment by session).  A significant effect of treatment was further analyzed 
for each drug condition by a one-way repeated measures ANOVA.  Dunnett’s post-hoc 
analysis with comparison to day one values was used when appropriate.  Significant 
interactions were analyzed in the same manner, but also included comparison of 
treatment within each acquisition or extinction session using the Tukey post-hoc test.  
The accepted level of significance for the tests was p<0.05.   
 
 
 
 
RESULTS 
 
Rimonabant fails to affect Barnes maze acquisition 
 
Rimonabant (3 mg/kg) failed to alter path lengths under both aversive (fig. 11A; 
p=0.14) and appetitive (fig. 12A; p =0.75) conditioning tasks, though the drug-treated 
mice had significantly longer path lengths than vehicle-treated mice on day 4, only. 
Similarly, rimonabant failed to affect the latency to enter the goal box during acquisition 
in aversive (fig. 11B; p=0.09) and appetitive (fig. 12B; p=0.18) conditioning Barnes 
maze procedures.  Rimonabant failed to affect speed during acquisition in the aversive 
(fig. 11C; p=0.68) and appetitive (fig. 12C; p=0.13) conditioning tasks.  During the first 
few conditioning sessions, the rimonabant-treated mice displayed more immobility than 
vehicle-treated mice, as indicated by significant interactions between drug treatment and 
conditioning day in aversive [fig. 11D; F(9,315)=2.3, p<0.05] and appetitive [fig. 12D; 
F(9,144)=2.0, p<0.05] procedures.   
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Figure 11: Rimonabant administration (3 mg/kg) increases immobility time, but does 
not affect acquisition of an aversively conditioned Barnes maze task.  The average 
distance (cm) traveled (panel A), and the corresponding latency (s) to enter the goal box 
(panel B), did not significantly differ between groups.  Panel C. No treatment 
differences were observed for adjusted speed [distance/(latency to enter – total time 
immobile)].  Panel D. Rimonabant increased time spent immobile during the first few 
conditional trials.  $ p<0.05 $$ p<0.01 vs. the corresponding vehicle-treated mice.  The 
data for each acquisition session are represented as the average of four daily trials ± 
SEM.  $ denotes a significant difference from vehicle treatment.  N=17-20 mice/group. 
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Figure 12:  Rimonabant administration (3 mg/kg) increases immobility time, but does 
not affect acquisition, in an appetitively conditioned Barnes maze task.  The average 
distance (cm) traveled (panel A), and the corresponding latency (s) to enter the goal 
box (panel B), did not significantly differ between groups.  Panel C. No differences 
were observed for adjusted speed [distance/(latency to enter – total time immobile)]. 
Panel D. A significant increase in time spent immobile was observed following 
rimonabant treatment.  $ p<0.05 vs. vehicle group.  The data for each acquisition 
session are represented as the average of four daily trials ± SEM.  N=9 mice/group. 
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Rimonbant disrupts extinction learning in an aversive, but not in an appetitive, Barnes 
maze task 
 
In an initial experiment, subjects were administered rimonabant or vehicle during 
both acquisition and extinction.  The percentage of time spent in the target zone in both 
groups across extinction trials is shown in fig. 13A, and track plots of a representative 
mouse for each treatment group on Day 1 and Day 10 of extinction are shown in fig. 15 
(top traces).  A significant drug by day interaction [F(9,306)=2.0, p<0.05] was found, 
indicating that the rimonabant-treated mice displayed a significant delay in extinction 
rate.  Whereas the vehicle control group underwent extinction following repeated trials 
without the goal box present [F(9,171)=9.1, p<0.0001], the rimonabant-treated group 
failed to display any evidence of extinction (p=0.76).  Specifically, the vehicle-treated 
mice spent significantly less time in the target zone by extinction day 2, while 
rimonabant-treated animals continued to perseverate in the target zone throughout all 10 
extinction trials.  Rimonabant treatment did not affect speed (fig. 13B; p=0.79), or 
distance traveled (p=0.60; data not shown), but did significantly increase the amount of 
time spent immobile [fig. 13C; F(1,306)=4.4, p<0.05].   
In the next experiment, rimonabant was administered before each extinction 
session, but not during acquisition.  Again, administration of rimonabant led to extinction 
deficits, as indicated by the percentage of time spent in the target zone [fig. 13D; 
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F(9,126)=2.2, p<0.05].  The vehicle-treated mice showed a reduction in the percentage of 
time spent in the target area [F(9,63)=8.2, p<0.0001], with a significant decrease in the 
target zone by day 3.  On the other hand, rimonabant-treated mice continued to 
perseverate in the target zone across all ten extinction sessions, with no reductions 
(p=0.45).  As in the previous experiment, rimonabant failed to affect adjusted speed (fig. 
13E; p=0.58); however, rimonabant treatment failed to produce a significant effect on 
immobility time [fig. 13F; F(1,126)=3.6, p=0.07].   
In the appetitive Barnes maze conditioning paradigm, rimonabant failed to alter 
extinction learning.  Both rimonabant- and vehicle-treated subjects exhibited a gradual 
reduction in the percentage of time spent in the target zone [fig. 14A; F(9,126)=6.1, 
p<0.0001].  However, neither a main effect of drug (p=0.68) nor an interaction between 
drug and extinction day (p=0.99) was observed.  Finally, there were no significant effects 
of treatment condition on adjusted speed (fig. 14B; p=0.57), distance traveled (p=0.59; 
data not shown), or time spent immobile (fig. 14C; p=0.79).  Representative traces of 
vehicle-treated and rimonabant-treated mice on Days 1 and 10 of extinction are shown in 
Figure 15 (bottom panel). 
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Figure 13: Rimonabant impairs extinction learning in the aversively motivated Barnes 
maze task.  In the first experiment (left panels), subjects were administered vehicle or 
rimonabant(3 mg/kg) before each acquisition and extinction trial, whereas rimonabant 
was only administered before each extinction session in the second experiment (right 
panels).  In both experiments, rimonabant, but not vehicle, treatment produced a 
perseverant effect in the target zone across ten daily, 3-min extinction trials, based on 
the percentages of time spent in the zone that previously contained the escape box 
(panels A and D).  The dotted line from the 16.7% point of the ordinate spanning to 
the width of the abscissa indicates chance performance.  Panels B and E. No treatment 
effect was observed for either experiment on adjusted speed [distance/(180 – total time 
immobile)].  Rimonabant treatment significantly increased time spent immobile (s) in 
experiment 1 (panel C), but not in experiment 2 (panel F, p=0.07).  * p< 0.05; ** 
p<0.01 vs. extinction day 1 for each respective group.  $ p<0.05 vs. the vehicle group.  
All data are represented as mean ± SEM.   N=8-20 mice/group. 
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Figure 14: Rimonabant fails to affect extinction learning in an appetitively 
conditioned Barnes maze task.  Panel A. Both rimonabant and vehicle treatment 
groups exhibited a significant decrease in the percentage of time spent in the target 
zone, which previously contained the goal.  The dotted line from the 16.7% point of 
the ordinate spanning to the width of the abscissa indicates chance performance.  
Adjusted running speeds [distance/(180 – total time immobile); panel B], as well as 
total time spent immobile (panel C) were unaffected by treatment condition.  All data 
are represented as mean ± SEM.  N=7-9 mice/group. 
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Figure 15: Track plots of representative vehicle- and rimonabant-treated mice in 
aversive (top panels) and appetitive (bottom panels) conditioning procedures on Days 
1 and 10, from the experiments presented in figures 13 and 14.  The target zone (i.e., 
the area that previously contained the goal box) for each trace is highlighted.  
Additionally, the plots have been rotated to display the target zone at the bottom. 
 
 
 
 
DISCUSSION 
 
 
 
Rimonabant treatment disrupted extinction learning under aversive, but not under 
appetitive conditions.  These data strongly support the hypothesis that the 
endocannabinoid system mediates learning under aversive conditions, but is dispensable 
for appetitively-motivated learning (Holter et al., 2005).  Unlike previous reports, this 
study represents the first case investigating the neurochemical mechanisms underlying 
extinction learning in which the same behavioral demands were required (i.e. locating 
and entering the goal box) and only the reinforcement was varied.  Control mice trained 
in either the aversive or appetitive Barnes maze conditioning paradigm showed a gradual 
decline in the percentage of time spent in the target zone across the extinction trials.  The 
rimonabant-treated mice trained in the aversive conditioning procedure continued to 
spend significantly more time in the zone that previously contained the escape box than 
each of the other zones throughout extinction training.  In contrast, the vehicle-treated 
mice showed a gradual decline in the percentage of time spent in the target zone across 
the extinction trials.  Conversely, in the appetitive task, rimonabant-treated mice showed 
a virtually identical decrease in the percentage of time spent in target zone as vehicle-
treated mice.  Importantly, previous control experiments demonstrated extinction learning 
was independent of forgetting, under both appetitive and aversive conditions.   
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These data support the initial hypothesis of Holter et al., (2005) that the 
endocannabinoid system is dispensable for extinction learning in an appetitively-
motivated learning tasks.  Specifically, they found CB1 -/- and +/+ mice displayed similar 
extinction rates in an operant nose-poke for food paradigm.  Similarly, Niyuhire et al, 
(2007) reported that rimonabant administration (1 or 3 mg/kg) failed to alter extinction 
rates in an appetitively-motivated operant conditioning paradigm in which the mice were 
trained to press a lever for access to sweetened milk, though rimonabant administration 
produced a reduction in the extinction burst on the first extinction trial.  Finally, Ward et 
al (2007) found no differences in extinction learning between CB1 -/- and +/+ mice.  
There are three alternative explanations for the apparent lack of evidence 
supporting endocannabinoid modulation of appetitively motivated extinction.  First, 
disruption of CB1 receptor signaling has been demonstrated to decrease salience of food 
reward (Ward and Dykstra, 2005), decreased salience for palatable sucrose solution 
(Higgs et al., 2003), and reduce operant responding for food (De Vry and Jentzsch, 2004; 
Holter et al., 2005; Ward et al., 2007).  It is important to note that Holter et al., (2005) 
employed a more stringent deprivation schedule in the CB1 -/- mice than the wild type 
counterparts in order to ensure that both genotypes displayed similar response rates. 
Similarly, Ward et al., (2007) analyzed extinction as a percentage of baseline responding 
during maintenance sessions.  Nonetheless, in both experiments the CB1 -/- mice still 
displayed equivalent extinction rates as the wild type mice.  Second, recent evidence has 
emerged showing that CB1 -/- mice exhibit an accelerated and age-related deficit in 
cognitive ability, which was associated with the loss of hippocampal neurons beginning 
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at three months of age (Bilkei-Gorzo et al., 2005).  Importantly, Holter et al.,(2005) 
utilized CB1 -/- mice that were 11-14 weeks and Ward et al., (2007) used 7-8 month-old 
mice (Ward, October 2007, Personal Communication), corresponding with significant 
cognitive deficits found by Bilkei-Gorzo et al.(2005) in other learning paradigms.  Thus, 
the age-related neurodegeneration in the CB1 -/- mice may play a contributing role in the 
reported extinction deficits, though this explanation would not hold for rimonabant-
treated animals.    
A third challenge in interpreting the role of the endogenous cannabinoid system 
on extinction learning is the difficulty in comparing the results of experiments across 
different behavioral paradigms.  Each of the reports examining appetitively motivated 
conditioning tasks employed an operant procedure, which has qualitatively different 
behavioral demands than learning paradigms employing either electric shock as the 
unconditioned stimulus (i.e., conditioned freezing and passive avoidance) or the Morris 
water maze. Thus, it may be that extinction of operant behavior, rather than the hedonic 
value of the reinforcer, is refractory to CB1 receptor disruption.  Moreover, the reinforcers 
in the conditioned freezing, passive avoidance, Morris water maze, and operant tasks are 
qualitatively different and not interchangeable.  To focus on the qualitative nature of the 
reinforcer, we modified the Barnes maze task in the present study to evaluate appetitively 
and aversively motivated conditioning procedures on extinction, but required the same 
motor responses (i.e., searching and entering the goal box).  Additionally, we departed 
from employing highly palatable food rewards in favor of water to limit confounding 
variables related to motivational factors.  Notably, rimonabant administration does not 
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affect water consumption (Arnone et al., 1997), an observation supported by the present 
study. The differential effects of rimonabant on extinction in our two Barnes maze tasks 
support the hypothesis that the endocannabinoid system is dispensable for the extinction 
of appetitively motivated behaviors.  
While we have previously employed the Morris water maze to evaluate the role of 
the endogenous cannabinoid system on extinction, this task is inherently aversive 
(Morris, 1984) .  This notion is supported by the observation that water maze training 
activates the pituitary adrenal axis, causing an increase in corticosterone (Sandi et al., 
1997; Akirav et al., 2001).  In contrast, the Barnes maze spatial memory paradigm 
presented a unique opportunity of comparing different sources of reinforcement, either 
aversive or appetitive (i.e. food and entering the goal box), to motivate the same goal.  
Only a handful of published reports have employed the Barnes maze to evaluate mice and 
most of this work has relied on similar sources of aversive reinforcement, such as bright 
lights, air turbulence, or auditory stimuli (Bach et al, 1995; Fox et al, 1998; Williams et 
al, 2003; Pompl et al, 1999; Inman-Wood et al, 2000; Bredy et al, 2004).  Conversely, 
other studies have utilized positive reinforcement, such as food, gentle handling, or the 
return to the home cage to motivate Barnes maze learning (Grootendorst et al, 2001; 
Williams et al, 2003; Blizard et al, 2003; Koopmans et al, 2003; Harrison et al, 2006).  In 
concert with results from the Morris water maze spatial memory paradigm, rimonabant 
treatment disrupted extinction learning in the aversive conditioning task.  Furthermore, 
our results indicate that rimonabant administration during acquisition is not necessary to 
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affect extinction in aversive conditions.   In contrast, rimonabant failed to affect 
extinction learning in the appetitive version of the task. 
Rimonabant did not affect acquisition of either an appetitively- or an aversively- 
conditioned Barnes maze task.  These data are in agreement with previous results from 
the Morris water maze (Varvel et al., 2005), passive avoidance (Mazzola et al., 2003; 
Niyuhire et al., 2007), conditioned fear (Marsicano et al., 2002; Suzuki et al., 2004; 
Kamprath et al., 2006; Niyuhire et al., 2007), and operant conditioning paradigms 
(Mallet and Beninger, 1998; Niyuhire et al., 2007).  Of interest, rimonabant treatment 
significantly increased immobility time under both aversive and appetitive conditions of 
reinforcement.  One possible explanation for the increased immobility time is an 
anxiogenesis, and is supported by the observation that rimonabant dose-dependently 
increases plasma corticosterone (Patel et al., 2004; Wade et al., 2006; Steiner et al., 
2008).  However, indistinguishable performance during the first extinction trial would 
suggest that both vehicle and rimonabant treated subjects acquired the task to a 
comparable degree.   
Pharmacotherapies directed at the endocannabinoid system hold potential promise 
for the treatment of a variety of maladies including, pain and inflammation (Lichtman et 
al., 2004; Hohmann et al., 2005), obesity (Rinaldi-Carmona et al., 1994), drug abuse 
(Arnone et al., 1997), diabetes (Anthenelli and Despres, 2004), anxiety (Gaetani et al., 
2003; Kathuria et al., 2003), depression (Gobbi et al., 2005; Hill and Gorzalka, 2005), 
and possibly post traumatic stress syndrome (Marsicano et al., 2002; Chhatwal et al., 
2005; Varvel et al., 2007).  The results presented here provide compelling evidence that 
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the endocannabinoid system mediates the extinction of behaviors that are associated with 
aversive memories, leaving extinction of learned behaviors from appetitively reinforced 
tasks intact.  While it is unknown whether the endocannabinoid system is involved in the 
extinction of other forms of positively reinforced (e.g. mating) behavior, the system’s 
impact on aversively motivated learning is clear.  These results underscore the concern 
over the therapeutic use of rimonabant or other cannabinoid receptor antagonists.  
Specifically, contraindication might be warranted for patients diagnosed with 
posttraumatic stress syndrome, as this disorder is believed to contain an element in which 
patients display deficits in extinguishing certain maladaptive behaviors associated with 
anxiety or panic attacks (Rothbaum and Davis, 2003).  This observation is further 
supported by a recent meta-analysis of rimonabants clinical trials, reporting a 40% 
increase in side effects ranging from depression and anxiety to suicidal thoughts 
(Christensen et al., 2007).   Conversely, pharmacotherapies that enhance 
endocannabinoid signaling, such as FAAH inhibitors or a cannabinoid receptor agonists, 
may accelerate extinction of aversively motivated behaviors.  In conclusion, the results of 
the present study are the first to show a differential effect of rimonabant on extinguishing 
a learned behavior that only differed in the hedonic nature of the reinforcer. 
 
 
 
 
 
 
 
 
EXPERIMENT 3 
 
 
 
 
INTRODUCTION 
 
 
 
A growing body of research has employed genetically altered mice to examine the 
role that the endocannabinoid system plays on learning.  However, conflicting reports 
exist regarding how acquisition is affected, and under what conditions.  Genetic 
disruption of CB1 receptor signaling enhances acquisition of an active avoidance 
paradigm (Martin et al., 2002), but impairs contextual conditioned fear (Mikics et al., 
2006), and delay eyeblink conditioning (Kishimoto and Kano, 2006).  On the other hand, 
CB1 -/- mice display similar acquisition as wild-type mice in the Morris water maze 
(Varvel and Lichtman, 2002; Varvel et al., 2005), cued conditioned fear (Marsicano et 
al., 2002; Cannich et al., 2004; Kamprath et al., 2006), and trace eyeblink conditioning 
(Kishimoto and Kano, 2006) tasks.   Differences in procedural demands may underlie the 
disparate nature of these reports. 
Under conditions of appetitive reinforcement, a more uniform collection of results 
have been reported.  Bilkei-Gorzo et al., (2005), were the first to report intact acquisition 
of an operant conditioning procedure in young (6-7 weeks of age) CB1 -/- mice compared 
to age-matched controls.  However, mature (3-5 months old) and old (14-17 months) CB1 
-/- mice exhibited an accelerated age-dependent decline in acquisition of the task 
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compared to controls, suggesting differences in age warrant consideration when 
interpreting results from studies utilizing CB1 -/- mice .  For example, acquisition 
learning was unaffected in operant conditioning experiments utilizing mature CB1 -/- and 
+/+ mice trained to nose-poke for food pellets (Holter et al., 2005), Ensure (a sweetened 
protein drink), or corn-oil (Ward et al 2007; Ward, personal communication, 2007).  
However, as CB1 -/- mice exhibit reduced motivation for food-reward, the extent to 
which phenotypic differences in hedonics may have contributed to these results remains 
unknown (Holter et al., 2005; Ward and Dykstra, 2005; Ward et al., 2007). 
For this dissertation, I developed a novel Barnes maze procedure in which a 
variable source of reinforcement (i.e., aversive or appetitive) is used to motivate the 
acquisition of a consistent goal (i.e., finding and entering the goal box).  Application of 
this new procedure presented the opportunity to clarify the relative importance of 
procedural demands and hedonics, with regards to the expression of genotypic 
differences in acquisition learning.  Age-matched CB1 -/- and +/+ litter-mate controls 
were given acquisition training under conditions of aversive or appetitive reinforcement 
conditions.  In the appetitive procedure, the mice were water restricted and access to 
water served as the appetitive reinforcer.  Importantly, water consumption is unaffected 
by genetic deletion of the CB1 receptor (Poncelet et al., 2003; Thanos et al., 2005).  The 
initial objective of this study was to provide a complementary approach to previous 
studies utilizing rimonabant during extinction.  However, the data presented here 
revealed an impaired acquisition phenotype in CB1 -/- mice, confounding the 
interpretation of extinction results.  Thus, the purpose of this study was to compare the 
86 
 
consequence of CB1 receptor deletion in acquisition of appetitive and aversive Barnes 
maze conditioning procedures.  To this end, we tested the hypothesis that acquisition 
deficits associated with CB1 receptor deletion are dependent hedonics, and CB1 -/- mice 
would exhibit impaired acquisition and extinction learning under aversive, but not 
appetitive, reinforcement conditions.   
 
 
 
 
METHODS 
 
 
SUBJECTS 
 
Subjects included CB1 -/- (n=17) and CB1 +/+ (n=17) mice between 8-16 weeks 
of age, on the C57BL/6 background that were born from breeding pairs at Virginia 
Commonwealth University.  The original breeding pairs were obtained from Zimmer et 
al., (1999).  All subjects were housed in a temperature-controlled (20-22º C) 
environment, with a 12-h light/dark cycle and ad libitum access to food.  In the appetitive 
condition, the same methodology as previously described was utilized.  In short, subjects 
were deprived of access to water for 22 h per day.  Upon completion of each acquisition 
session, subjects were allowed access to water for 2 h per day.  All experiments were 
approved by the Institutional Animal Care and Use Committee at Virginia 
Commonwealth University.  
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PROCEDURE 
 
Two types of testing conditions were used: aversive and appetitive.  In the 
aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide fans 
(Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and 
remained on during all stages and trials.  In the appetitive procedure, a modified goal box 
containing access to water was used as a reinforcer for water-deprived mice. Subjects 
were given 22 h of daily water deprivation before each session and were weighed for 
comparison to a pre-deprivation baseline.  Immediately after each session, the mice were 
returned to their home cages, given access to water for 2 h, and weighed.   
 
Shaping 
Shaping occurred as described previously.  In summary, all subjects were 
acclimated to the apparatus and basic procedure before formal acquisition training began.  
The subject was placed in the start cylinder and released.  Three min later, the subject 
was placed in the goal box, which was then slid into one of the six corresponding target 
locations.  Following two min of acclimation to the goal box, the mouse was placed into 
its home cage for a 30 s intertrial interval (ITI).  After the ITI, the goal box was placed 
back into its corresponding location and the subject was guided from the center of the 
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maze to the entrance of the goal box.  Shaping was concluded after at least two 
consecutive entries into the goal box without provocation from the investigator.  
Acquisition 
Again, the same acquisition procedure as previously described was employed.  
Each mouse was given four acquisition trials per day for ten days.  Each trial ended when 
either three min had elapsed or the subject entered the goal box, whichever occurred first.  
In the event that the mouse failed to enter the goal box within the three min trial, it was 
placed in the center of the maze and the experimenter led it to the goal box where it 
remained for 30 s before being returned to its home cage for the 30 s ITI.  If the mouse 
repeatedly found the goal box, but failed to enter, it was given additional shaping in 
which it was again placed in the center of the maze and led to the escape hole, a process 
that was repeated until the mouse entered the goal box without provocation from the 
experimenter.  Acquisition measures included test duration (latency to enter the hidden 
goal box), total time spent immobile, distance traveled, and adjusted speed 
[distance/(latency to enter – time immobile)].  
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STASTICAL ANALYSES 
 
AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate the 
dependent measures of interest.  As reported, measures of interest included adjusted 
speed (distance traveled/(latency to enter – time immobile)), distance traveled, time spent 
immobile, and latency to enter the goal box (test duration).  
Results from comparison studies were analyzed using two-way mixed design 
ANOVAs (genotype by session).  A significant effect of genotype was further analyzed 
for each genotype condition by a one-way repeated measures ANOVA.  Dunnett’s post-
hoc analysis with comparison to day one values was used when appropriate.  Significant 
interactions were analyzed in the same manner, but also included comparison of genotype 
within each acquisition session using the Tukey post-hoc test. 
 
 
 
 
RESULTS 
 
 
CB1 -/- mice exhibit deficits in acquiring an aversively conditioned Barnes maze task 
 
 
Under the aversive conditioning procedure, both CB1 -/- and  +/+ mice acquired 
the task in a manner consistent with previous experiments, exhibiting a gradual reduction 
in distance traveled [fig. 16A; F(9,144)=20.6, p<0.0001], latency to enter [fig. 16B; 
F(9,144)=30.9, p<0.0001], and time immobile [fig. 16C; F(9,144)=4.7, p<0.0001]. 
Genetic ablation of the CB1 receptor disrupted acquisition learning, exhibited by a 
significant genotype effect of distance [F(1,144)=18.5. p<0.001], as well as the 
corresponding latency to enter [F(1,144)=26.4, p<0.0001].  While no genotype 
differences were observed for adjusted speed [fig. 16D; p=0.76], CB1 -/- mice spent 
significantly more time immobile than CB1 +/+ mice [F(1,144)=18.9, p<0.001]. 
 Significant interactions were observed for both latency to enter [F(9,144)=1.95, 
p<0.05] and time immobile [F(9,144)=2.20, p<0.05].  In each case, post-hoc analysis 
revealed significantly different values starting on acquisition day one (p<0.01).  
Furthermore, significant differences on the final acquisition day suggest acquisition 
deficits in CB1 -/- mice perseverate despite continued acquisition training.   
 Analysis of the first four acquisition trials on day one resulted in a similar pattern 
of results.  A significant effect of trial was observed for the latency to enter [Fig. 17B; 
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F(3,48)=4.9, p<0.01], distance traveled [Fig. 17A; F(3,48)=10.8, p<0.0001], and adjusted 
speed [fig. 17D; F(3,48)=3.9, p<0.05].  In contrast, no significant effect of trial on 
immobility time was found [Fig. 17C; F(3,48)=2.0, p=0.11].  Again, CB1 -/- mice 
required a greater amount of time to enter the goal box, resulting in a significant effect of 
genotype [F(1,48)=14.1, p<0.01].  Notably, none of the CB1 -/- mice entered the goal box 
on the first trial, likely contributing to the significant difference on day one, as shown in 
fig. 17B.   Despite similar performance on the first trial, the disparity in immobility time 
between genotypes seen in the final three trials was sufficient to produce a significant 
effect of genotype [F(1,48)=11.6, p<0.01].    Furthermore, control animals exhibited no 
change in the amount of time spent immobile across trials, while CB1 -/- mice exhibited a 
consistent increase in immobility, following the first trial.  Finally, the genotypes did not 
differ with regards to adjusted speed [F(1,48)=.35, p=0.55]. 
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Figure 16: CB1 -/- mice exhibit deficits in acquiring an aversively motivated Barnes 
maze task.  Distance (cm) traveled (panel A), and corresponding latency (s) to enter 
(panel B) were significantly elevated in CB1 -/- mice compared to wild-type controls.  
Panel C.  A significant effect of genotype was observed for time immobile (s).  Panel 
D.  No genotype differences were observed for adjusted speed [distance/(latency to 
enter – total time immobile)].  * p<0.05 ** p<0.01 vs. the corresponding CB1 (+/+) 
mice.  The data for each acquisition session are represented as the average of four 
daily trials ± SEM.  N=9 mice/group.   
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Figure 17:  CB1 -/- mice exhibit impaired acquisition on the first day of an aversively 
motivated Barnes maze task.  No genotype differences were observed for distance 
(cm) traveled (panel A).  Significantly greater latency (s) to enter (panel B) the goal 
box, as well as time (s) spent immobile (panel C) were observed in CB1 -/- mice 
compared to CB1 +/+ mice.  The data are represented as the mean ± SEM.  N=9 
mice/group.   
 
95 
 
CB1 -/- mice exhibit deficits in acquiring an appetitively conditioned Barnes maze task 
 
 
Figure 18 A-D illustrate the primary dependent measures for acquisition of an 
appetitively conditioned Barnes maze task across ten days of acquisition.  A significant 
effect of day was observed for distance [fig. 18A; F(9,126)=30.3, p<0.0001], latency to 
enter [fig. 18B; F(9,126)=37.6, p<0.0001], time immobile [fig. 18C; F(9,126)=4.0, 
p<0.0001], and adjusted speed [fig. 18D; F(9,126)=4.9, p<0.0001]; indicating both CB1 -
/-  and CB1 +/+ mice acquired the task. 
While both genotypes learned the task, significant genotype differences in 
acquisition were observed for both latency to enter [F(1,126)=7.2, p<0.05], and distance 
traveled [F(1,126)=8.9, p<0.01].  In both cases, CB1 -/- mice consistently traveled further, 
and took more time to enter the escape box, than their wild-type littermates, illustrating 
impaired acquisition of the task.  In agreement with the aversive paradigm, genetic 
deletion of the CB1 receptor resulted in a significant increased time immobile compared 
to wild-type controls [F(1,126)=4.6, p<0.05].  Finally, analysis of adjusted speed revealed 
a significant genotype by day interaction [F(9,126)=2.5, p<0.01].  However, post-hoc 
analyses revealed that genotypes only differed significantly on days seven and nine 
(p<0.05).   
 Unlike the aversive condition, analysis within the first acquisition day failed to 
yield any significant genotype differences [distance: p=0.08 (Fig. 19A), latency to enter: 
p=0.08 (Fig. 19B), time immobile: p=0.15 (Fig. 19C), adjusted speed: p=0.48 (Fig. 
19D)].   Notably, mean values for all dependent measures on trial one were 
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indistinguishable between groups, suggesting significant differences across all ten 
acquisition days were not confounded by differences in initial baseline performance. 
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Figure 18:  CB1 -/- mice exhibit impaired acquisition of an appetitively reinforced 
Barnes maze task.  Distance (cm) traveled (panel A), and corresponding latency (s) to 
enter (panel B) were significantly elevated in CB1 -/- mice compared to wild-type 
controls.  Panel C.  CB1 -/- spent significantly more time immobile (s) than their CB1 
+/+ controls.  Panel D.  a significant genotype by day interaction was observed for 
adjusted speed [distance/(latency to enter – total time immobile)].  * indicates a 
significant difference from CB1 -/- mice.  * p<0.05 The data for each acquisition 
session are represented as the average of four daily trials ± SEM.  N=8 mice/group.   
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Figure 19:  CB1 -/- mice acquire the Barnes maze task under appetitive conditions on 
acquisition day one.  The average distance (cm) traveled (panel A), and the 
corresponding latency (s) to enter (panel B), did not significantly differ between 
genotypes.  Panel C.  No genotype differences were observed for time immobile (s).  
Panel D.  Adjusted speed [distance/(latency to enter – time immobile)] did not differ 
between genotypes.  The data for each trial are represented as mean ± SEM.  N=8 
mice/group. 
 
 
 
 
DISCUSSION 
 
 
 
 
 CB1 receptor -/- mice displayed impaired acquisition learning under both aversive 
and appetitive conditions.  These data suggest that acquisition deficits in CB1 -/- mice are 
independent of the hedonic nature of the reinforcer.  While we initially sought to evaluate 
extinction learning in CB1 -/- mice as a complementary approach to previous studies 
utilizing rimonabant, the impaired acquisition phenotype of CB1 -/- mice confounded 
interpretation of results.  Unlike previous reports investigating acquisition learning 
following genetic deletion of the CB1 receptor, the procedure employed here utilized the 
same behavioral demands (e.g. locating and entering the goal box) under varied 
conditions of reinforcement (i.e. aversive and appetitive). Under both aversive and 
appetitive conditions, CB1 +/+ mice exhibited acquisition learning on par with our 
previous results, exhibiting a gradual decline in the latency to enter the goal box, as well 
as a reduction in the concurrent distance traveled.  Conversely, CB1 -/- mice displayed an 
increased path length, and required more time to enter the goal box relative to their wild-
type littermates.  CB1 -/- mice exhibited impaired acquisition under both aversive and 
appetitive conditions, suggesting that the behavioral demands of the task, and not the 
source of reinforcement, are primarily responsible for the results presented here.   
 These data are in agreement with previous reports illustrating acquisition deficits 
in CB1 -/- mice in aversively reinforced paradigms including contextual conditioned fear 
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(Mikics et al., 2006), and delay eyeblink conditioning paradigms (Kishimoto and Kano, 
2006).  However, alternative paradigms dependent on aversive reinforcement have 
exhibited enhanced, or intact acquisition performance.  For example, CB1 -/- mice 
exhibited enhanced acquisition in the active avoidance paradigm(Martin et al., 2002), as 
well as social and object recognition tasks (Reibaud et al., 1999; Maccarrone et al., 2002; 
Bilkei-Gorzo et al., 2005); and normal acquisition of spatial memory (Varvel and 
Lichtman, 2002; Varvel et al., 2005), cued conditioned fear (Marsicano et al., 2002; 
Cannich et al., 2004; Kamprath et al., 2006), and trace eyeblink conditioning (Kishimoto 
and Kano, 2006).  Conversely, in appetitively reinforced paradigms, CB1 -/- mice show 
no impairment in acquiring operant conditioning (Bilkei-Gorzo et al., 2005; Holter et al., 
2005; Ward et al., 2007). 
 There are five possible explanations that may account for the lack of continuity in 
the literature.  First, the primary challenge in interpreting these data is the confounding 
nature of comparing results across dissimilar behavioral paradigms.  Differences in the 
nature of reinforcement, as well as behavioral demands associated with qualitatively 
different learning paradigms, preclude direct comparison across studies.  For example, 
previous reports utilizing appetitive reinforcement have relied on operant condition 
paradigms, which have little in common with the behavioral demands of the Barnes maze 
task.  Ultimately, differences in procedural demands may be fundamental in unmasking 
differences in acquisition performance between genotypes.  
 Second, exogenous administration of CB1 receptor agonists have been 
demonstrated to increase the salience of food reward (Abel, 1975; Ward and Dykstra, 
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2005).  Concurrently, pharmacological or genetic attenuation of CB1 receptor signaling 
has been demonstrated to decrease the salience and motivation for a diverse array of 
palatable substances including high carbohydrate, high fat, and standard lab chow food-
pellets (Verty et al., 2004; McLaughlin et al., 2006); sweet sucrose solutions (Arnone et 
al., 1997; Higgs et al., 2003; Sanchis-Segura et al., 2004);  the high-protein solution 
Ensure® (Ward and Dykstra, 2005); and high-fat corn-oil (Ward and Dykstra, 2005).  
Together, these reports illustrate the problematic nature of interpreting acquisition 
performance following eCB manipulation, independent of changes in the hedonic value 
of appetitive reward.  In the current study, access to water within the goal box reinforced 
acquisition learning in water-deprived subjects.  As water consumption is unaffected by 
manipulations of the eCB system (Arnone et al., 1997; Colombo et al., 1998; Poncelet et 
al., 2003; Thanos et al., 2005) the results presented here are suggested as independent of 
confounds related to changes in the hedonic value of the appetitive reward.  
   Third, the importance of controlling for age in CB1 -/- mice has been 
underestimated until recently, and may also account for the lack of continuity among 
results.  Bilkei-Gorzo et al., (2005) were the first to report an accelerated age-related 
decline in both cognitive performance and the density of hippocampal neurons, beginning 
at three months of age.  As subjects in the aversive paradigm were approximately twelve 
to sixteen weeks of age, the aforementioned decline in cognitive performance may have 
contributed to the impairment of acquisition learning.  However, despite controlling for 
age in the appetitive condition (i.e. subjects were six to eight weeks of age), acquisition 
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deficits were still evident, suggesting that while age may exacerbate acquisition deficits, 
it does not fully account for its occurrence. 
Fourth, given the age-related decline in hippocampal morphology following CB1 
receptor deletion, it is important to note that hippocampal injury is correlated with 
impaired acquisition learning in the Barnes maze (Fox et al., 1998; Paylor et al., 2001; 
Deacon and Rawlins, 2002; Raber et al., 2004) and other spatial memory tasks (Morris, 
1984; Logue et al., 1997).  Moreover, disruption of hippocampal function impairs 
contextual fear conditioning (Phillips and LeDoux, 1992; Logue et al., 1997), and spatial 
mapping (Sutherland et al., 1982).  In contrast, damage to the hippocampus appears 
independent of performance in cued spatial memory tasks (Morris, 1984; Fox et al., 
1998), as well as cued conditioned fear (Phillips and LeDoux, 1992; Logue et al., 1997).  
Together, these reports underscore differences in substrate demands associated with 
disparate learning tasks, and may contribute to the conflicting results presented here, and 
those previously established.  
Finally, in addition to disrupting acquisition of the Barnes maze task, genetic 
attenuation of CB1 receptor signaling produced a significant increase in immobility time, 
independent of the conditioning procedure.  These data would suggest that processes 
unrelated to learning and memory may be contributing to the observed acquisition 
deficits.  As the aversive paradigm is assumed to be more anxiogenic than the appetitive 
paradigm, this hypothesis is further supported by the observation that all CB1 -/- mice 
failed to enter the goal box on the first trial of day one in the aversive paradigm.  
Importantly, the caveat that CB1 -/- mice failed to enter the goal box on the first trial 
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because they found the Barnes maze less aversive than wild-type mice deserves attention.  
However, this explanation appears unlikely as repeated Barnes maze exposures would 
result in habituation to the stressful stimuli, gradually decreasing the anxiety provoked by 
aversive stimuli.  In turn, habituation to the stress of Barnes maze exposure would 
increase the probability of electing not to enter the goal box in favor of remaining on the 
maze.  In contrast, both CB1 -/- and +/+ mice exhibited a reduction in the latency to enter 
across successive trials.     Further supporting the hypothesis that processes unrelated to 
learning may be responsible for the effects reported here is the report of similar 
phenotypic differences in CB1 null mutant mice by Varvel & Lichtman (2002) in the 
Morris water maze.  Unlike wild-type controls, CB1 -/- mice were characterized by 
labored motor behavior, a propensity for floating, seizures that ultimately resulted in 
death, and the development of incompatible swim strategies (i.e. repetitive circling 
behaviors).  Ultimately, half of these mice were removed from the study for failing to 
reach inclusion criteria.  Similar methodological considerations designed to normalize 
performance between genotypes have been reported, including increased food deprivation 
(Holter et al., 2005), or comparison to baseline performance (Ward et al., 2007).  
Together, the diversity in methodology, statistical transformations, and inclusion criteria 
may play a primary role in determining whether anxiety-like behaviors are reported.    
There is a growing body of literature supporting eCB modulation of stress and 
anxiety.   CB1 receptors expression occurs at different levels controlling the HPA axis, 
such as the hippocampus and amygdala (Marsicano and Lutz, 1999; Mackie, 2005), 
hypothalamus (Cota et al., 2003), the pituitary (Wenger et al., 1999), and adrenal glands 
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(Galiegue et al., 1995).  Administration of the CB1 receptor antagonist rimonabant dose-
dependently increases plasma corticosterone and ACTH (Manzanares et al., 1999; Wade 
et al., 2006; Steiner et al., 2008), and is potentiated by restraint stress (Patel et al., 2004; 
Steiner et al., 2008).  In rats, chronic unpredictable stress significantly increases plasma 
corticosterone, and reduces hippocampal, but not limbic forebrain, CB1 receptor protein 
expression by 50% (Hill et al., 2005a).  Similarly, CB1 -/- mice exhibit higher basal 
levels of plasma corticoserone and ACTH (Barna et al., 2004; Cota et al., 2007; Steiner 
et al., 2008), and hyper-responsiveness to stress (Barna et al., 2004; Steiner et al., 2008), 
as well as CRH- and forskolin-induced ACTH secretion (Cota et al., 2007).  While HPA 
axis dysregulation in CB1 -/- mice has been postulated to arise from developmental 
deficits (Wade et al., 2006), a recent report by Steiner et al., (2007) would suggest this is 
not the case, as results in CB1 -/- mice were replicated following rimonabant 
administration.  Together, these reports, as well as the data presented here, support a role 
of CB1 receptor signaling as a mechanism for dampening stress-induced corticosterone 
secretion; independent of genetic background, type of stressor, or method of CB1 receptor 
disruption (e.g. pharmacological vs. genetic).  In relation to the present study, differences 
in basal corticosterone secretion may contribute to the observed increase in immobility 
time.  Observationally, CB1 -/- mice spent an unusual amount of time immobile adjacent 
to the goal box entrance prior to entering.  This observation would explain for 
consistently greater values for latency to enter and time immobile, and accounts for the 
eventual asymptotic performance between genotypes with respect to distance traveled.  
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However, anything beyond speculation warrants further elucidation of stress responses 
following Barnes maze exposure.    
The impact of chronic eCB disruption, either through cannabis use or 
pharmacological antagonism, on cognition remains unclear.  The results presented here 
provide considerable evidence that long-term inactivation of eCB signaling disrupts both 
aversively and appetitively reinforced acquisition learning.  Furthermore, as the 
qualitative behavioral demands of the task were unchanged between reinforcement 
conditions, these data are the first to compare acquisition performance while controlling 
for procedural differences.  A notable caveat that remains undetermined is the possible 
involvement of confounds related to genetic knockout mice, including genetic drift, 
compensatory changes, and downstream developmental alterations (Taft et al., 2006).  
These data are in conflict with previous results indicating that acquisition learning is 
unaffected by pharmacological CB1 receptor antagonism.  In fact, the only consistent 
result between studies was increased immobility time in both aversively and appetitively 
motivated procedures.  The lack of continuity between studies would suggest that 
impaired acquisition learning in CB1 -/- mice is a result of confounds associated with 
gene deletion, or chronic attenuation of CB1 receptor signaling.  To address this 
uncertainty, future studies evaluating Barnes maze acquisition learning following chronic 
administration of rimonabant are warranted.  Nonetheless, these data raise the intriguing 
possibility that chronic disruption of eCB signaling may ultimately take a substantial toll 
on certain mnemonic processes.       
 
 
 
 
 
 
EXPERIMENT 4 
 
 
INTRODUCTION 
 
 
The results of studies utilizing direct acting cannabinoid agonist administration 
has contributed in a growing acceptance that the eCB system modulates cognitive 
processes.  However, confounds associated with exogenous CB1 agonist administration, 
such as disruptive effects on motor behavior and memory, preclude the interpretation of 
results as simulating endogenous activity (Pamplona and Takahashi, 2006).  In contrast, 
the recent availability of FAAH -/- mice (Cravatt et al., 2001), and FAAH inhibitors 
provide an alternative approach to evaluate eCB function by inhibiting the metabolism of 
the endocannabinoid anandamide, in effect magnifying and prolonging eCB signaling.  
Already, a growing body of research would suggest FAAH inhibitors as a potential 
pharmacotherapeutic with regards to disorders of depression (Gobbi et al., 2005; Naidu et 
al., 2007), anxiety (Kathuria et al., 2003; Patel and Hillard, 2006; Naidu et al., 2007), 
pain (Lichtman et al., 2004), and cognition (Varvel et al., 2006; Varvel et al., 2007).    
The disruptive effects of exogenously administered CB1 agonists on acquisition 
learning have been exhibited in rodents (Varvel et al., 2001) and humans (Chait and 
Pierri, 1992).  However, the impact of enhancing endogenous eCB signaling on cognitive 
processes remains enigmatic.  Varvel et al., (2006) were the first to report an 
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enhancement of working memory in FAAH -/- mice during acquisition of the Morris 
water maze spatial memory task.  In this experiment, FAAH -/- mice displayed 
accelerated acquisition rates compared to wild-type littermates.  In a follow-up 
experiment by the same group, FAAH -/- mice again exhibited enhanced acquisition, this 
time of a fixed-platform task (Varvel et al, 2006).  While these data suggest enhancing 
eCB signaling facilitates acquisition learning, the lack of alternative studies in the 
literature underscore the current inability to elucidate the conditions and extent to which 
these effects are unmasked.     
Procedural differences associated with disparate tasks, as well as the hedonic 
nature of the reinforcer can determine the absence or expression of eCB modulated 
cognitive effects.  For example, the disruption of extinction learning following 
rimonabant administration is primarily dependent on the nature of the reinforcer.  As we 
have shown, rimonabant disrupts extinction learning under aversive, but not appetitive 
conditions.   Conversely, CB1 -/- mice exhibit impaired acquisition of both aversive and 
appetitively conditioned Barnes maze spatial learning.  However, as these studies 
evaluated attenuated CB1 receptor signaling, the extent to which these observations 
generalize to enhanced eCB signaling remain unknown. 
The present study utilized the Barnes maze procedure in which a variable source 
of reinforcement (i.e. aversive or appetitive) motivates the acquisition of a consistent goal 
(i.e. entering the goal box).  Application of this new procedure presented the opportunity 
to clarify the relative importance of procedural demands and hedonics, with regards to the 
expression of genotypic differences in acquisition learning.  The primary purpose of this 
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experiment was to test the hypothesis that FAAH -/- mice would exhibit enhanced 
acquisition under aversive, but not appetitive, conditioning procedures.  Furthermore, we 
postulated a CB1 receptor mechanism of action for enhanced acquisition in FAAH -/- 
mice.  To this end, a separate study was conducted in which FAAH -/- were administered 
the CB1 receptor antagonist, rimonabant, or vehicle.  As the same procedure was used, 
differences were controlled and only the source of reinforcement was manipulated, we 
sought to determine if the enhancement of acquisition learning observed in FAAH -/- 
mice is dependent on the nature of the reinforcer. 
 
 
 
 
 
METHODS 
 
 
SUBJECTS 
 
FAAH -/- mice (n=44) were derived from FAAH -/- congenic breeding pairs that 
had been back-crossed onto a C57BL/6J background approximately 14 generations.  
FAAH +/+ (n=32) mice used in the study were produced by FAAH +/+ parents derived 
from a cross between a FAAH -/- congenic parent mated with a C57BL/6J from Jackson 
labs.  The resulting +/- offspring were then crossed with C57BL/6J mice to derive +/+ 
breeding pairs.  All FAAH -/- and FAAH +/+ mice were bred from breeding pairs in 
Virginia Commonwealth University (Lichtman et al., 2004).  All subjects were housed in 
a temperature-controlled (20-22º C) environment, with a 12-h light/dark cycle and ad 
libitum access to food, and in the aversive condition, water.  In the appetitive condition, 
the same methodology as previously described was utilized.  In short, subjects were 
deprived of access to water for 22 h per day.  Upon completion of acquisition trials, 
subjects were allowed access to water for 2 h per day.  All experiments have been 
approved by the Institutional Animal Care and Use Committee at Virginia 
Commonwealth University.  
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PROCEDURE 
 
Two types of testing conditions were used: aversive and appetitive.  In the 
aversive procedure, bright lights (two, 500 watt halogen bulbs) and two, 60 cm wide fans 
(Holmes, Milford, MA) for air turbulence were located 120 cm above the maze and 
remained on during all stages and trials.  In the appetitive procedure, a modified goal box 
containing access to water was used as a reinforcer for water-deprived mice. Subjects 
were given 22 h of daily water deprivation before each session and were weighed for 
comparison to a pre-deprivation baseline.  Immediately after each session, the mice were 
returned to their home cages, given access to water for 2 h, and weighed.   
 
Shaping 
Shaping occurred as described previously.  In summary, all subjects were 
acclimated to the apparatus and basic procedure before formal acquisition training began.  
The subject was placed in the start cylinder and released.  Three min later, the subject 
was placed in the goal box, which was then slid into one of the six corresponding target 
locations.  Following two min of acclimation to the goal box, the mouse was placed into 
its home cage for a 30 s intertrial interval (ITI).  After the ITI, the goal box was placed 
back into its corresponding location and the subject was guided from the center of the 
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maze to the entrance of the goal box.  Shaping was concluded after at least two 
consecutive entries into the goal box without provocation from the investigator.  
Acquisition 
Again, no deviations in acquisition procedure were employed.  Each mouse was 
given four acquisition trials per day for ten days.  Each trial ended when either three min 
had elapsed or the subject entered the goal box, whichever occurred first.  In the event 
that the mouse failed to enter the goal box within the three min trial, it was placed in the 
center of the maze and the experimenter led it to the goal box where it remained for 30 s 
before being returned to its home cage for the 30 s ITI.  If the mouse repeatedly found the 
goal box, but failed to enter, it was given additional shaping in which it was again placed 
in the center of the maze and led to the escape hole, a process that was repeated until the 
mouse entered the goal box without provocation from the experimenter.  Acquisition 
measures included test duration (latency to enter the hidden goal box), total time spent 
immobile, distance traveled, and adjusted speed [distance/(latency to enter – time 
immobile)].  
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STASTICAL ANALYSES 
 
AnyMaze (Stoelting, Wood Dale, IL) software was used to accumulate the 
dependent measures of interest.  As reported, measures of interest included adjusted 
speed [distance traveled/(latency to enter – time immobile)], distance traveled, time spent 
immobile, and latency to enter the goal box (test duration).  
Results from comparison studies were analyzed using two-way mixed design 
ANOVA (genotype by session).  A significant effect of genotype was further analyzed 
for each genotype condition by a one-way repeated measure ANOVA.  Dunnett’s post-
hoc analysis with comparison to day one values was used when appropriate.  Significant 
interactions were analyzed in the same manner, but also included comparison of genotype 
within each acquisition session using the Tukey post-hoc test. 
 
 
 
 
 
 
RESULTS 
 
 
FAAH -/- mice exhibit enhanced acquisition of an aversively conditioned Barnes maze 
task 
 
 
 
 
 Under conditions of aversive reinforcement both FAAH -/- and +/+ mice acquired 
the Barnes maze task, resulting in a significant effect of day for latency to enter [fig. 20B; 
F(9,126)=35.2, p<0.0001], distance traveled [fig. 20A; F(9,126)=18.7, p<0.0001], time 
immobile [fig. 20C; F(9,126)=3.5, p<0.001], and adjusted speed [fig. 20D; 
F(9,126)=13.4, p<0.0001]. 
 Comparison between genotypes resulted in a significant effect of latency to enter, 
characterized by accelerated improvement in the task by FAAH -/- mice compared to 
wild-type controls, resulting in both a significant effect of genotype [F(1,126)=22.2, 
p<0.001] as well as a genotype by day interaction [F(9,126)=2.1, p<0.05].  While FAAH 
-/- mice spent significantly less time immobile than FAAH +/+ mice, resulting in a 
significant effect of genotype [F(1,126)=11.7, p<0.01], the FAAH  -/- mice also showed 
significantly higher mean running speed [F(1,126)=9.9, p<0.01] (data not shown), which 
persisted when time immobile was accounted for (i.e. adjusted speed) [F(1,126)=9.7, 
p<0.01].   
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 Analysis within the first day of acquisition resulted in a significant effect of trial 
for duration [fig. 21B; F(3,42)=4.0, p<0.05], but not distance [fig. 21A; p=0.14], time 
immobile [fig. 21C; p=0.19], or adjusted speed [fig. 21D; p=0.07].   
No significant genotype effects were observed on the first acquisition day for all 
measures [distance: p=0.13, time immobile: p=0.8, adjusted speed: p=0.15] with the 
exception of latency to enter [F(1,42)=4.9, p<0.05].  Notably, genotype differences for 
latency to enter were most prominent on trial three and four whereas on the first trial, 
both genotypes exhibited similar starting latencies.  The absence of any significant 
genotype differences during the first trial would suggest that differences between 
genotypes on day one in figure 20 are not confounded by learning that may have occurred 
during shaping.   
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Figure 20:  FAAH -/- mice show enhanced acquisition of an aversive Barnes maze 
procedure.  No differences between genotypes were observed for distance (cm) 
traveled (panel A), however, the corresponding average latency (s) to enter (panel B) 
significantly differed between genotypes.  FAAH -/- mice spent significantly less time 
(s) immobile (panel C), and displayed a greater adjusted speed [distance/(latency to 
enter – total time immobile)] compared to FAAH +/+ controls.  * p<0.05 ** p<0.01 
vs. FAAH -/- mice.  The data for each acquisition session are represented as the 
average of four daily trials ± SEM.  * denotes a significant difference from FAAH -/- 
mice.  N=8 mice/group. 
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Figure 21:  FAAH -/- mice exhibit enhanced acquisition within the first acquisition 
day of an aversive Barnes maze procedure.  No genotype differences were observed 
for distance (cm) traveled (panel A).  Panel B.  A significant genotype effect was 
observed for latency (s) to enter the goal box with FAAH -/- acquiring the task faster 
than wild-type controls.  No genotype differences were observed for the amount of 
time (s) spent immobile (panel C), or adjusted speed [distance/(latency to enter – time 
immobile)].  All data are represented as mean ± SEM.  N=8 mice/group. 
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FAAH -/- mice display normalized acquisition under appetitive conditions 
 
 Under appetitive conditions, analysis of FAAH -/- and +/+ mice across ten days 
of acquisition resulted in a significant effect of acquisition day for distance traveled [fig. 
22A; F(9,162)=17.9, p<0.0001], latency to enter [fig. 22B; F(9,162)=41.3, p<0.0001], 
time immobile [fig. 22C; F(9,162)=12.5, p<0.0001], and adjusted speed [fig. D; 
F(9,162)=10.4, p<0.0001].   
 While these results illustrate the occurrence of acquisition learning, only time 
immobile significantly differed between genotypes [F(1,162)=7.6, p<0.05].  In contrast to 
the aversive paradigm, exposure to the appetitive condition increased the average amount 
of time spent immobile in the FAAH -/- mice compared to FAAH +/+ controls.  
However, no other genotype differences were observed (latency to enter: p=0.15, distance 
traveled: p=0.40, adjusted speed: p=0.70). 
 Within the first acquisition day, a significant effect of trial was observed for 
distance traveled [fig. 23A; F(3,54)=10.3, p<0.0001], latency to enter [fig. 23B; 
F(3,54)=6.9, p<0.001], time immobile [fig. 23C; F(3,54)=2.9, p<0.05], and adjusted 
speed [fig. 23D; F(3,54)=3.5, p<0.05].  However, no significant differences between 
genotypes (latency to enter: p=0.10, distance traveled: p=0.77, time immobile: p=0.81, 
adjusted speed: p=0.06), or genotype by day interactions, were observed, indicating that 
performance was not affected by the shaping procedure.  
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Figure 22:  FAAH -/- mice show normal acquisition in an appetitively motivated 
Barnes maze task.  No genotype effects were observed for distance (cm) traveled 
(panel A), or the corresponding latency (s) to enter the goal box (panel B).  A 
significant effect of genotype on the amount of time (s) spent immobile (panel C) was 
observed.  Panel D.  Analysis of adjusted speed [distance/(latency to enter – time 
immobile)] revealed no differences between genotypes.  The data from each 
acquisition session are represented as the average of four daily trials ± SEM.  N=10 
mice/group. 
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Figure 23:  FAAH -/- mice show normal acquisition of an appetitive Barnes maze 
task, within the first day.  No genotype effects were observed for distance (cm) 
traveled (panel A), or the corresponding latency (s) to enter the goal box (panel B).  
No differences were observed between genotypes based on time (s) spent immobile 
(panel C), or adjusted speed [distance/(latency to enter – time immobile)].  All data are 
represented as the average of each trial within the first acquisition day ± SEM.  N=10 
mice/group.  
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Rimonabant (1mg/kg) Administration does not affect Barnes Maze Acquisition 
 
  
Future experiments would utilize rimonabant to test the hypothesis that the 
enhancement of acquisition, observed in FAAH -/- mice, is dependent on CB1 receptor 
signaling.  However, as a 3 mg/kg dose of rimonabant has been show to increase 
immobility during acquisition of the Barnes maze task, characterization of a lower dose 
was necessary to determine if similar effects would be elicited.  A 1 mg/kg dose was 
chosen as it has been shown to attenuate the behavioral effects of i.v. THC, without 
producing locomotor disturbances when administered alone (Compton et al., 1996).   
 Administration of rimonabant or vehicle 30 min before exposure to the aversively 
conditioned Barnes maze task did not affect acquisition learning, indicated by the 
absence of significant treatment effects (Fig. 24A; distance: p=0.94; Fig 24B.; duration: 
p=0.16; Fig. 24C; time immobile: p=0.16; Fig. 24D adjusted speed: p=0.36), or treatment 
by day interactions (duration: p=0.59; distance: p=0.92; time immobile: p=0.29; adjusted 
speed: p=0.57).  Independent of treatment, the occurrence of acquisition learning was 
denoted by a significant effect of acquisition day for all dependent measures, including 
distance [F(2,20)=8.8, p<0.01], the corresponding latency to enter [F(2,20)=27.3, 
p<0.0001], time immobile [F(2,20)=11.7, p<0.001], and adjusted speed [F(2,20)=8.2, 
p<0.01].
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Figure 24:  Rimonabant (1mg/kg i.p.) does not affect acquisition learning in an 
aversively reinforced Barnes maze task.  No differences were observed for distance 
traveled, or the corresponding latency to enter the goal box.  Panel C.  Rimonabant 
treatment does not affect the average time spent immobile.  Panel D.  No differences 
were observed for adjusted speed [distance/(duration – time immobile)].  All data are 
represented as the average of four daily trials ± SEM.  N=6 mice/group. 
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Rimonabant attenuates the enhancement of acquisition in FAAH -/- mice under aversive 
conditions 
 
 To determine if genotype differences in acquisition were CB1 mediated, FAAH -/- 
mice were administered either 1 mg/kg rimonabant or vehicle and compared to vehicle-
injected FAAH +/+ controls.  A significant effect of trial was observed for distance 
traveled [fig. 25A; F(9,333)=61.6, p<0.0001], latency to enter [fig. 25B; F(9,333)=104.8, 
p<0.0001], time immobile [fig. 25C; F(9,333)=10.7, p<0.0001], and adjusted speed [fig. 
25D; F(9,333)=26.0, p<0.0001].   
Comparison between groups failed to indicate differences in motor behavior 
between groups, either for distance traveled [F(2,333)=1.6, p=0.21] or adjusted speed 
[F(2,333)=1.4, p=0.25].  However, a significant group difference for latency to enter 
[F(2,333)=3.6, p<0.05], as well as a group by day interaction [F(18,333)=1.7, p<0.05], 
was observed.  Post-hoc analysis indicated that FAAH -/- mice administered vehicle were 
significantly different than FAAH -/- mice administered rimonabant (p<0.05).  However, 
comparison to respective day one values using Dunnett's test indicated that all groups 
showed significant improvement (p<0.01) starting on day two.   
 Further differences were observed between groups when time spent immobile was 
analyzed by repeated measures ANOVA.  In this case, a significant effect of group 
[F(2,333)=4.2, p<0.05] as well as a group by day interaction [F(18,333)=2.0, p<0.01] 
were observed.  Similar to duration, Tukey post-hoc analysis revealed a significant 
difference between FAAH -/- mice administered rimonabant or vehicle.  However, only 
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FAAH -/- mice administered vehicle exhibited a significant (p<0.01) reduction in time 
spent immobile by day 2, following Dunnett’s comparison to the first acquisition day.   
 Analysis within acquisition day one revealed a significant effect of trial for the 
dependent measures distance [fig. 26A; F(3,111)=6.0, p<0.001], and latency to enter [fig. 
26B; F(3,111)=3.6, p<0.05], but not time immobile (Fig. 26C, p=0.15) or adjusted speed 
(Fig. 26D, p=0.71).  No significant effects of group (duration: p=0.20; distance: p=0.44; 
time immobile: p=0.15; adjusted speed: p=0.92), or group by trial interactions (duration: 
p=0.86; distance: p=0.93; time immobile: p=0.39; adjusted speed: p=0.55), were 
observed. 
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Figure 25:  Rimonabant administration (1 mg/kg) attenuates the enhancement of 
acquisition in FAAH -/- mice under aversive conditions.  Rimonabant or vehicle was 
administered i.p. 30-min prior to testing on each acquisition day.  No differences were 
observed on distance (cm) traveled, however a significant effect of condition was 
observed for the corresponding latency (s) to enter the goal box (panel B).  A 
significant effect of condition was also observed for time (s) spent immobile (panel 
C).  Panel D.  Analysis of adjusted speed [distance/(latency to enter – time immobile)] 
failed to reveal any significant differences between conditions.  * indicates a 
significant difference between FAAH -/- + RIM and FAAH -/- + Vehicle groups.  * 
p<0.05.  All data are represented as the average of four daily trials ± SEM.  N= 13-14 
mice/condition. 
 
125 
 
 
 
 
 
 
 
Figure 26:  Rimonabant (1 mg/kg) does not affect acquisition in FAAH -/- mice 
within the first acquisition day of an aversively conditioned Barnes maze task.  
Rimonabant or vehicle was administered i.p. 30-min prior to the first acquisition trial.  
No differences between conditions were observed for distance (cm) traveled (panel 
A), or the corresponding latency (s) to enter the goal box (panel B).  Panel C.  No 
differences were observed for time immobile (s).  Panel D.  Adjusted speed 
[distance/(latency to enter – time immobile)] failed to yield any significant differences 
between conditions.  All data are represented as the average of each trial ± SEM.  
N=13-14 mice/condition. 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
   
 
FAAH -/- mice exhibited enhanced acquisition learning in an aversive, but not an 
appetitive, Barnes maze task.  These data support the hypothesis that stimulating eCB 
signaling enhances acquisition of an aversively reinforced spatial memory task (Varvel et 
al., 2007).  Furthermore, as the behavioral demands (i.e. locating and entering the goal 
box) remained unchanged between reinforcement conditions, to our knowledge this is the 
first report to illustrate the enhancement of acquisition following FAAH deletion as 
dependent on reinforcement conditions.  The data also extend the hypothesis that the eCB 
system mediates extinction learning under aversive conditions, but is dispensable for 
appetitively-motivated learning (Holter et al., 2005) to include acquisition learning.  
While we initially proposed evaluating extinction learning, FAAH +/+ mice failed to 
exhibit decreased perseverant behavior in the target zone, confounding interpretation of 
results.  
During initial acquisition sessions in the aversive paradigm, FAAH -/- mice 
required less time than their wild-type counterparts to achieve the goal of the task, 
entering the hidden goal box.  A similar pattern of results was observed within the first 
acquisition day, as FAAH -/- mice required less time to enter the goal box, resulting in a 
significant effect of genotype.  As both genotypes exhibited similar latencies within the 
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first trial, the observed effects are independent of learning that may have occurred during 
shaping.  Importantly, the CB1 receptor antagonist rimonabant attenuated the 
enhancement, indicating the effects were specific to the FAA anandamide.  In the 
appetitive conditioning procedures, no differences between genotypes were observed 
with regards to the latency to enter the goal box.  Consequently, the aforementioned 
effects on acquisition learning are specific to aversive conditions. 
 An unexpected finding in these experiments was that the adjusted speed under 
aversive conditions of the FAAH -/- mice was significantly quicker than for the FAAH 
+/+ mice, suggesting that the decreased escape latencies in the FAAH -/- mice can be 
accounted by differences in motor behavior, and is further supported by the observation 
that genotypes did not differ in the distance traveled to complete the task.  While initial 
reports utilizing exogenous administration of AEA have shown a hypomotile response, 
(Crawley et al., 1993; Fride and Mechoulam, 1993; Smith et al., 1994) it is generally 
accepted that this approach does not mimic endogenous function given AEA’s short half-
life in vivo (i.e. <5 min.) (Willoughby et al., 1997).   In contrast, inhibition of FAAH 
provides an alternative approach by inhibiting the metabolism of endogenously released 
anandamide, in effect magnifying and prolonging the physiological response.   Genetic 
and pharmacological approaches to FAAH inhibition have suggested motor behavior is 
unaffected in the open-field test (Cravatt et al., 2001; Cippitelli et al., 2007; Moreira et 
al., 2008), and elevated plus maze (Naidu et al., 2007).  Conversely, in the fixed platform 
Morris water maze (Varvel et al., 2007) paradigm, the authors report a significant 
increase in swim speed in FAAH -/- mice, as well as enhanced acquisition.  Similar to the 
128 
 
aversive conditioning Barnes maze paradigm, the methodology employed in the Morris 
water maze utilized aversive reinforcement to motivate learning a fixed goal location in a 
spatial memory task (Morris, 1982).  Thus, aversive reinforcement appears to be 
necessary to unmask genotype differences in motor behavior and/or acquisition of spatial 
memory.   
 Alternatively, the enhancement of acquisition presented here may reflect 
alterations in emotionality and attentional processes.  Specifically, pharmacological 
inhibitors of FAAH have been reported to produce an anxiolytic response in several 
murine models of emotionality (Kathuria et al., 2003; Viveros et al., 2005; Bortolato et 
al., 2006; Patel and Hillard, 2006; Naidu et al., 2007).  Likewise, both pharmacological 
and genetic attenuation of eCB signaling have been shown to produce anxiogenesis 
(Navarro et al., 1997; Arevalo et al., 2001; Haller et al., 2002; Maccarrone et al., 2002; 
Martin et al., 2002; Rodgers et al., 2005; Patel and Hillard, 2006).   As we have shown 
previously, CB1 -/- mice spend more time immobile and exhibit acquisition deficits when 
exposed to the aversively conditioned Barnes maze paradigm, supporting the initial 
hypothesis that heightened emotionality contributes to the disruption of spatial memory 
learning (Ferrari et al., 1999).  Furthermore, as FAAH -/- mice spent significantly less 
time immobile, and acquired the task faster than controls the results, the data would 
suggest the eCB system facilitates learning under aversive conditions by dampening the 
expression of anxiety.   
 In contrast to the results from the aversive paradigm, FAAH -/- mice spent 
significantly more time immobile than controls in the appetitive conditioning procedure.  
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As eCB’s are presumed to be released on demand in response to aversive stimuli (Di 
Marzo et al., 1994; Marsicano et al., 2002; Marsicano et al., 2003; Piomelli, 2003; 
Hohmann et al., 2005), it is possible that the conditions associated with the appetitive 
paradigm are insufficient to increase eCB signaling.  However, this explanation does not 
account for the increase in immobility time under the appetitive conditioning procedure.  
However, it deserves mentioning that immobility is a very complex phenotype and may 
result from multiple factors in addition to freezing, including fear and arousal.   
Alternatively, the rewarding value of escaping an aversive situation may be 
enhanced in FAAH -/- mice.  Evidence suggesting the endocannabinoid and 
dopaminergic systems work in tandem to activate reward processes is further supported 
by observations that increase FAAH inhibition increases motivation for ethanol and food 
consumption (Giuffrida et al., 1999; De Vries et al., 2001; Di Marzo et al., 2001; 
Blednov et al., 2007; Soria-Gomez et al., 2007).  However, these observations do not 
adequately account for the observation that FAAH -/- mice spend significantly more time 
immobile under appetitive conditions.   Instead, compensatory changes associated with 
genetic FAAH deletion may account for these observations.  Given that only the source 
of reinforcement was altered in the present experiment, differences in hedonics between 
the aversive and appetitive paradigm would appear to be of primary importance.  For 
example, uncharacterized alterations in hedonics associated water deprivation, or water 
consumption, might occur following genetic manipulation.  However, the latter 
explanation appears insufficient as FAAH -/- mice show a preference for water 
containing ethanol, but not sucrose or quinine, in the two-bottle choice paradigm 
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(Basavarajappa et al., 2006; Blednov et al., 2007).  Thus, it appears future experiments 
are required to elucidate possible genotype differences in motivation following water 
deprivation.   
 As FAAH is primarily responsible for the metabolism of many FAAs (i.e. AEA, 
oleamide, PEA, and OEA) (Cravatt et al., 1996), we used rimonabant to determine 
whether the phenotypic acceleration in acquisition was CB1 receptor mediated.  Indeed, 
rimonabant normalized acquisition learning in FAAH -/- mice to the same rate as FAAH 
+/+ mice, implicating a CB1 receptor mechanism of action, as well as the involvement of 
the only FAAH substrate with relevant cannabinoid activity, anandamide.  Of interest, 
rimonabant treatment increased the amount of time spent immobile in FAAH -/- mice to 
levels indistinguishable from vehicle treated controls, providing evidence that FAAH -/- 
mice display a CB1 receptor mediated anxiolytic response to aversive conditions.  
Importantly, we have shown that the dose of rimonabant used in the current experiment 
(1 mg/kg) does not affect Barnes maze performance. 
 In conclusion, the results provided here provide evidence that the eCB system 
modulates acquisition under aversive conditions, but is dispensable for appetitively-
motivated learning.  Furthermore, these data suggest FAAH inhibitors be useful as an 
alternative pharmacotherapy in treating anxiety disorders.  Currently, the most 
predominant pharmacological treatment remains GABA agonists, which are 
characterized by generalized anxiolysis and side-effects such as learning and memory 
disruptions, and abuse liability.  In contrast, FAAH inhibitors appear to exert their 
anxiolytic properties under specific conditions such as exposure to aversive conditions 
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(Naidu et al., 2007), lack side-effects associated with cannabinoid agonists (Lichtman et 
al., 2004), and facilitate certain mnemonic processes.   
 
 
 
 
 
 
GENERAL SUMMARY 
 
 
 
 
 The data presented here support the following conclusions: 1) Mice acquire, and 
extinguish the Barnes maze task under both appetitive and aversive conditions of 
reinforcement, 2) Rimonabant does not impair the acquisition of either an appetitively or 
aversively conditioned Barnes maze task, 3) Rimonabant disrupts extinction learning of 
an aversive, but not an appetitive, Barnes maze task, 4) Extinction learning is 
independent of forgetting, 5) Compared to CB1 +/+ mice, CB1 -/- mice exhibit deficits in 
acquiring both an aversive and appetitive Barnes maze task, and 6) FAAH -/- mice 
acquire an aversively, but not appetitively, conditioned Barnes maze task faster than 
FAAH +/+ controls. 
 The initial objective of these studies was to develop, and characterize, a paradigm 
in which the source of reinforcement varied, and the goal of the task remained constant.  
To this end, we adapted the Barnes maze task (Barnes, 1979) so that bright lights and air 
turbulence motivated learning under aversive conditions, and access to water reinforced 
learning under appetitive conditions.  Importantly,  previous research has demonstrated 
that alterations in eCB signaling can affect a subject’s motivation to work for palatable 
food (De Vry and Jentzsch, 2004; Holter et al., 2005; Ward and Dykstra, 2005), but does 
not alter water consumption (Arnone et al., 1997; Colombo et al., 1998; Poncelet et al., 
2003; Thanos et al., 2005).  As subsequent studies focused on manipulations to the 
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endogenous cannabinoid system, we departed from the use of palatable food reward in 
favor of access to water under appetitive conditions. 
 We evaluated three conditioning procedures in the Barnes maze task: appetitive, 
aversive, and ambient.  In the aversive condition, bright lights and air turbulence 
motivated learning the task.  Conversely, in the appetitive condition, subjects were water 
deprived and the goal box was modified to provide access to water.  Finally, conditions 
common to both the aversive and appetitive procedure (i.e., no bright lights, air 
turbulence, or water deprivation) were utilized for the ambient conditioning paradigm.  
Subjects in each condition displayed normal acquisition learning, exhibiting gradual 
improvement in their ability to complete the task, based on the latency and distance 
traveled to enter the hidden goal box.  Under conditions common to both the appetitive 
and aversive conditions, subjects in the ambient conditioning group consistently traveled 
further, spent more time immobile, and took longer than their aversively or appetitively 
conditioned counterparts.  These findings suggest that the added source of motivation, 
either aversive or appetitive, accelerate and improve acquisition of the Barnes maze task.  
In addition, the results also suggest that Barnes maze exposure is sufficient to motivate 
learning the task, possibly through an innate aversion to open fields, or the intrinsic 
reward value of the goal box.  
 During extinction of the task, the goal box was removed and subjects in each 
condition were given a three min probe trial, and the percentage of time spent in the 
target zone, the zone which was formerly associated with the goal box, was used as a 
measure of extinction learning.  Subjects in all three reinforcement conditions 
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extinguished the task, exhibiting a gradual reduction in the percentage of time in the 
target zone following repeated exposures to the Barnes maze.  Importantly, a control 
experiment was performed to distinguish forgetting from extinction learning.  In this 
experiment, subjects were divided into two groups following acquisition.  While the first 
group (Group Extinction) received their first nine extinction trials, the second group 
(Group No Extinction) remained in the vivarium.  On the tenth and final extinction trial 
for Group Extinction, both groups were evaluated.  While Group Extinction exhibited a 
significant reduction in time spent in the target zone, Group No Extinction exhibited a 
preference for the target zone, indistinguishable from Group Extinctions first trial.  These 
results support the conclusion that mice extinguished the behavior, and did not merely 
forget the escape box location. 
 Having characterized Barnes maze acquisition and extinction learning under 
qualitatively different conditioning procedures, we tested the hypothesis that rimonabant 
would disrupt extinction learning under aversive, but not appetitive, conditions.  The 
hypothesis that rimonabant is dispensable for appetitively, but not aversively conditioned 
extinction learning, was first proposed by Holter et al., (2005) and recently supported by 
Niyuhire et al., (2007).  In both reports, attenuated CB1 receptor signaling, either 
pharmacological or genetic, did not significantly impair extinction of operant tasks.  In 
contrast, rimonabant and genetic deletion of the CB1 receptor disrupts extinction learning 
in a number of aversively reinforced procedures (Marsicano et al., 2002; Suzuki et al., 
2004; Varvel et al., 2005; Kamprath et al., 2006; Niyuhire et al., 2007).  However, the 
validity of the hypothesis by Holter et al., (2005) remains undetermined due in part to the 
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difficulty of reconciling between differences in hedonics and behavioral demands of 
disparate tasks.  Specifically, behavioral demands required by operant tasks (i.e. learning 
to press a lever for food reward) are qualitatively different from the Morris water maze 
(i.e. learning to locate and swim to a hidden platform) or conditioned freezing (i.e. 
learning a tone is predictive of a shock).  Furthermore, the experiments by Holter et al., 
and Niyuhire et al., utilized palatable food reward to reinforce operant learning.  As 
discussed, genetic and pharmacological antagonism of CB1 receptor signaling decreases 
the salience of food reward (Ward and Dykstra, 2005), as well as palatable sucrose 
solution (Higgs et al., 2003), and reduces operant responding for food (De Vry and 
Jentzsch, 2004; Holter et al., 2005; Ward et al., 2007).  To address these outstanding 
issues, we evaluated extinction learning in a Barnes maze task utilizing consistent 
behavioral demands, with a varying source of reinforcement.   
 Rimonabant treatment disrupted extinction learning under aversive, but not 
appetitive conditions.  These data strongly support the hypothesis that the 
endocannabinoid system mediates learning under aversive conditions, but is dispensable 
for appetitively-motivated learning (Holter et al., 2005).  Unlike previous reports, this 
study represents the first case in which the same behavioral demands were required (i.e. 
locating and entering the goal box) and only the source of reinforcement was varied.  
Control mice trained in either the aversive or appetitive Barnes maze conditioning 
paradigms showed a gradual decline in the percentage of time spent in the target zone 
across the extinction trials.  Conversely, rimonabant-treated mice trained in the aversive 
conditioning procedure spent significantly more time in the zone that previously 
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contained the escape box than each of the other zones.  In contrast, in the appetitive task, 
rimonabant-treated mice showed a virtually identical decrease in the percentage of time 
spent in the target zone as vehicle-treated mice.   
Rimonabant did not impair acquisition of either the aversively, or appetitively, 
conditioned Barnes maze task, exhibiting similar latencies and path lengths to enter the 
goal box across acquisition trials compared to vehicle-treated subjects.  However, 
rimonabant administration resulted in significantly more time spent immobile than 
vehicle treated mice under both conditions of reinforcement.   It is possible that the 
increased immobility time is an anxiogenic effect of rimonabant administration, as 
supported by the observation that rimonabant dose-dependently increases plasma 
corticosterone (Patel et al., 2004; Wade et al., 2006; Steiner et al., 2008).   However, 
future experiments are necessary to determine the validity of this hypothesis.   
Our second objective was to characterize acquisition performance of CB1 -/- mice 
in both the aversively and appetitively conditioned Barnes maze tasks.  Genetic deletion 
of the CB1 receptor produces a variety of learning effects which appear dependent on 
procedure.  For example, CB1 -/- mice exhibit enhanced acquisition of recognition 
memory in the object (Reibaud et al., 1999; Maccarrone et al., 2002) and social 
recognition paradigms (Bilkei-Gorzo et al., 2005); impaired acquisition of contextual 
conditioned fear and delay eyeblink conditioning (Kishimoto and Kano, 2006; Mikics et 
al., 2006); and normal acquisition of spatial memory (Varvel and Lichtman, 2002; Varvel 
et al., 2005), cued conditioned fear (Marsicano et al., 2002; Cannich et al., 2004; 
Kamprath et al., 2006), operant conditioning tasks (Bilkei-Gorzo et al., 2005; Holter et 
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al., 2005; Ward et al., 2007), and trace eyeblink conditioning (Kishimoto and Kano, 
2006).  However, results from appetitively reinforced operant paradigms are difficult to 
interpret due to confounds related to age, the choice of appetitive reinforcer, and 
inclusion criteria.  Specifically, Bilkei-Gorzo et al., (2005) were the first to report an 
accelerated age-related decline in both cognitive performance and the density of 
hippocampal neurons, beginning at three months of age.   The age of subjects from the 
studies by Ward et al., and Holter et al., utilized mice corresponded with the age-related 
deficits reported by Bilkei-Gorzo et al., possibly affecting results.  Furthermore, 
methodological considerations designed to normalize performance between genotypes 
have been reported, including increased food deprivation in CB1 -/- mice (Holter et al., 
2005), comparison to baseline performance (Ward et al., 2007), and the exclusion of 
subjects for exhibiting strange behavior or failing to reach criteria (Varvel et al., 2005; 
Ward et al., 2007).  To address these concerns, we utilized young, age-matched CB1 -/- 
and +/+ mice, departed from food reward in favor of access to water, and excluded 
acquisition criteria to test the hypothesis that CB1 -/- would exhibit impaired acquisition 
independent of reinforcement condition.   
CB1 -/- mice exhibited impaired acquisition of both the aversively and 
appetitively conditioned Barnes maze task compared to CB1 +/+ controls.  Independent of 
reinforcement condition, CB1 -/- mice traveled further, and required more time to achieve 
the goal of the Barnes maze task across acquisition trials.  Furthermore, CB1 -/- mice 
consistently spent more time immobile than their wild-type counterparts.  Of interest, 
both genotypes achieved asymptotic performance for only one of the aforementioned 
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dependent variables, distance traveled.  The observation that CB1 -/- mice tended to travel 
to the goal box entrance, and remained immobile for a variable interval prior to entering, 
may account for the consistently greater latency to enter and amount of time spent 
immobile.   Analysis of the first four trials of acquisition day one in the aversively 
conditioned paradigm revealed that the CB1 -/- mice had significantly longer latencies to 
enter the goal box, and increased time immobile compared to CB1 +/+ mice.  Conversely, 
no significant differences were found during analysis of the first four trials of the 
appetitively conditioned task.   
We initially attempted to assess extinction learning in CB1 -/- mice to provide a 
complementary approach to studies utilizing the pharmacological CB1 antagonist 
rimonabant.  However, acquisition deficits in CB1 -/- mice confounded the possible 
interpretation of extinction results.  Regardless, these reports support the hypothesis that 
disparate acquisition results previously reported between CB1 -/- and +/+ mice are due to 
differences in behavioral demands of qualitatively dissimilar tasks, rather than the 
hedonic nature of reinforcement.  Furthermore, two explanations may account for the 
observed differences between genotypes in the results garnered from the present 
experiments.  First, CB1 receptor deletion may impair critical aspects of acquisition 
learning, though the exact mechanisms (i.e. neuronal or behavioral) remain 
undetermined.  Alternatively, the act of entering the goal box may be inherently, and 
insurmountably, more aversive in CB1 -/- mice.  This explanation is supported by 
consistently greater latencies to enter the goal box, as well as the observation that CB1 -/- 
tended to remain immobile adjacent to the escape hole prior to entering. 
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The purpose of our final objective was to characterize acquisition learning in a 
genetic model of enhanced eCB signaling.  To this end, FAAH -/- and +/+ mice were 
evaluated in both the aversively and appetitively conditioned Barnes maze task.  
Currently, only two reports have been published evaluating acquisition performance in 
FAAH -/- mice.  In both cases, FAAH -/- mice exhibited enhanced acquisition of the 
Morris water maze task compared to FAAH +/+ controls (Varvel et al., 2006; Varvel et 
al., 2007).  However, it is unknown whether these results generalize to alternative 
memory models.  The Barnes maze task allowed us to evaluate two outstanding questions 
in relation to the works by Varvel et al., (2006, 2007).  First, would FAAH -/- mice 
exhibit enhanced acquisition in an alternative spatial memory paradigm with qualitatively 
different behavioral demands?  Second, is the enhancement of acquisition dependent on 
the conditioning procedure (i.e. aversive or appetitive)?  Thus, we evaluated the 
hypothesis that FAAH -/- mice will exhibit enhanced acquisition of the Barnes maze task 
under both appetitive and aversive conditioning procedures.  
FAAH -/- mice acquired the task faster than their +/+ counterparts in an 
aversively, but not an appetitively, conditioned Barnes maze task.  In relation to the work 
by Varvel et al., (2006, 2007) the present data suggest that enhanced acquisition of 
FAAH -/- mice are not limited by qualitatively different behavioral responses demanded 
by dissimilar spatial memory paradigms.  Under aversive conditions, FAAH -/- mice 
required less time to complete the task for the initial six days of acquisition, after which 
time both genotypes exhibited asymptotic performance.  However, no genotype 
differences were observed for the total distance traveled.  FAAH -/- mice also spent 
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significantly less time immobile, and traveled faster than FAAH +/+ mice.  As the 
measure ‘adjusted speed’ corrects for differences in immobility time, it is possible that 
FAAH -/- mice are better at performing the Barnes maze task because they run faster.  
This alternative explanation is supported by results from the dependent measure distance 
traveled, considered a more objective measure of learning than latency to enter, as no 
genotype differences were observed.   
Conversely, under the appetitive conditioning procedure, FAAH -/- and +/+ mice 
did not significantly differ in adjusted speed, the total distance traveled, or corresponding 
latency to enter the goal box.  In contrast with results from the aversively conditioned 
paradigm, FAAH -/- spent more time immobile than +/+ mice.  One possible explanation 
for the conflicting results is the hypothesis that endocannabinoids are released under 
aversive conditions.  If true, this would suggest that any aversiveness inherent to the 
appetitively conditioned paradigm, such as being exposed to an open area, is not 
sufficient to increase eCB signaling.   However, this explanation appears insufficient as it 
cannot account for the increase in immobility time observed in FAAH -/- mice under 
appetitive conditions.  Alternatively, compensatory changes associated with genetic 
deletion of FAAH may explain the increase in immobility time.  Regardless, immobility 
is a very complex phenotype and could be due to many different reasons in addition to 
freezing. 
Our final experiment tested the hypothesis that FAAH -/- mice exhibited 
enhanced acquisition through a CB1 mediated mechanism of action.  Inhibition of the 
FAAH enzyme results in significantly elevated levels of anandamide, as well as non-
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cannabinoid FAAs (Cravatt et al., 2001).  Among the non-cannabinoid FAAs are the 
sleep-inducing compound oleamide (OLE; Cravatt et al., 1995), the anti-inflammatory N-
palmitoylethanolamine (PEA; Lambert et al., 2002), and the appetite suppressing agent 
N-oleoylethanolamine (OEA; Rodriguez de Fonseca et al., 2002).  Anandamide is also an 
endogenous agonist at the TRPV1 receptor (zygmunt et al, 1999; Smart et al., 2000; Van 
der Stelt & DiMarzo, 2004).  The heat-activated TRPV1 receptor was first identified by 
its responsiveness to the compound capsaicin, isolated from hot chili peppers, and is 
purported to mediate responses to thermal and chemical pain (Caterina et al., 1997; 
Szallasi & Blumberg, 1999).  The purpose of this experiment was to determine if non-
specific cannabinoid mechanisms were responsible for the enhanced acquisition observed 
in FAAH -/- mice.  To this end, we used rimonabant to test the hypothesis that CB1 
antagonism attenuates the enhancement of acquisition observed in FAAH -/- mice. 
Rimonabant (1 mg/kg) administration in FAAH -/- mice resulted in performance 
indistinguishable from FAAH +/+ mice.  These results support the hypothesis that 
enhanced acquisition in FAAH -/- mice is mediated through a CB1 receptor dependent 
mechanism of action.  Furthermore, the results support the exclusion of non-cannabinoid 
FAAs as mediating acquisition effects in FAAH -/- mice.  In this experiment, we 
evaluated three groups: FAAH -/- mice receiving rimonabant, FAAH -/- mice 
administered vehicle, and FAAH +/+ mice administered vehicle.  Importantly, we 
utilized a dose of rimonabant (1 mg/kg) which we determined did not affect Barnes maze 
performance.  In agreement with previous results, the total distance traveled did not 
significantly differ between groups.  Furthermore, FAAH -/- mice administered vehicle 
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exhibited consistently lower values for the latency to enter the goal box, as well as 
immobility time.  As these effects were absence in FAAH -/- mice administered 
rimonabant, the results support a cannabinoid mechanism of action.  Finally, departing 
from previous observations, analysis of adjusted speed failed to reveal any significant 
differences between groups.  The conflicting adjusted speed results, between this study 
and the initial study comparing genotypes, are perplexing as the only difference in 
experimental procedure was the administration of drug or vehicle; suggesting the effect is 
either related to nonspecific effects associated with i.p. injection or an artifact resulting 
from unknown differences in cohorts. 
   
   
 
 
 
 
 
GENERAL DISCUSSION 
 
 
 
 
 We have identified three alternative explanations for the failure of rimonabant to 
disrupt extinction learning under appetitive conditions.  First, reduced motivation might 
result in a concomitant reduction in the performance, resulting in faster extinction.  
However, this does not appear likely as we observed asymptotic acquisition performance 
between appetitive and aversive conditioning procedures during methods development.  
Furthermore, control mice in the aversive condition exhibited a more robust decline in the 
percentage of time spent in the target zone during extinction trials when compared to 
control animals in the appetitive condition.  Second, cognitive impairments resulting 
from water deprivation may potentially contribute to weaker memory formation and 
faster extinction.  Again, this possibility is unlikely because both conditions displayed 
similar acquisition performance.  A third possibility is the eCB system is differentially 
involved in extinction, depending on the nature of reinforcement during extinction 
training, rather than during acquisition.  For example, extinction learning in classical 
conditioning models is reinforced by the omission of punishment, and can be regarded as 
rewarding.  Operant conditioning models, however, bear aspects of frustration as they 
rely on the omission of reward.  In the present experiment, the source of reinforcement 
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between conditions involved a similar aspect, omission of the goal box.  As rimonabant 
disrupted extinction learning in one condition, but not the other, it would appear that the 
results cannot be attributed to the involvement of eCB signaling in reward processes 
during extinction learning.   
The results presented here are grounded in the assumption that learning, either 
under the aversive or appetitive conditioning procedure, is motivated primarily by 
representative stimuli for each condition (i.e., bright lights and air turbulence for aversive 
procedures vs. access to water in appetitive procedures).  This assumption is supported by 
the observation that additional reinforcement, either aversive or appetitive, improved 
acquisition performance when compared to ambient reinforcement conditions.  These 
data also suggest that exposure to the Barnes maze is sufficiently aversive to motivate 
mice to escape an elevated, open field.  Alternatively, the goal box could be sufficiently 
rewarding or merely preferable to the maze. 
Water deprivation may be inherently aversive, producing a state of prolonged 
stress that result in untoward compensatory changes.  Rodents, like most animals, have 
evolved distinct physiological mechanisms enabling them to adapt to prolonged periods 
in which food or water may be unavailable.  As a result, it has been hypothesized rodents 
are equipped to handle dehydration periods for as long as 24 h without any overt signs of 
physiological stress or behavioral abnormalities (Rowland, 2007).  Among these adaptive 
mechanisms, is a reduction in food intake in the absence of access to water, resulting in 
‘dehydration anorexia’ (Watts, 1999).  Thus, there is potential for water-deprivation to 
produce a concomitant, food-deprived state.  However, in a study using rats subjected to 
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a dehydration paradigm, in which water was replaced with hypertonic saline, no 
alterations in feeding were observed until the second day of deprivation, suggesting a 
relatively slow onset of dehydration anorexia.  Furthermore, the authors reported a rapid 
reversal of anorexia within the first 30 min of free access to water (Watts, 1999).  As we 
have shown, mice subjected to our water restriction protocol quickly adapt to the 
procedure and are able to maintain their body weight appropriately.  Together, these 
results would support the observation by Rowland (2007) that rodents are able to entrain 
their ingestive responses to adapt to availability.  Water deprivation may also cause 
alterations in stress hormones.  However, in rats subjected to 48 h of water-deprivation, a 
slight but significant elevation in basal corticosterone, but not ACTH was observed.  In 
response to 15 min of restraint stress, no differences between water-deprived and control 
animals was observed for corticosterone levels, and ACTH levels decreased (Aguilera et 
al., 1993).  Furthermore, in a study where rats were restricted to 15 min access to water 
per day, no changes were observed with regards to open-field behavior, freezing 
behavior, or corticosterone levels.  In contrast, food-restriction to 80% baseline weight 
resulted in significantly greater activity in the open-field, and higher mean serum 
corticosterone (Heiderstadt et al., 1999).  While these results suggest that water 
restriction produces a negligible stress response, it is unknown whether adaptations occur 
with regards to the eCB system.  Thus, future studies designed to evaluate possible 
changes, such as CB1 receptor density or eCB content, deserve consideration.  
A growing body of research has implicated the endogenous cannabinoid system 
as modulating homeostatic mechanisms related to neuroendocrine responses to stress and 
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energy balance, and manifested as anxiety (Pagotto et al., 2006; Tasker, 2006).  The 
primary response to a stressor is activation of the hypothalamic-pituitary-adrenocortical 
(HPA) axis, and subsequent increase in plasma corticosterone.  Co-localization of CB1 
receptors at each level controlling HPA axis functioning has been shown, suggesting a 
multi-tiered role for eCB modulation of the stress response (Galiegue et al., 1995; 
Marsicano and Lutz, 1999; Wenger et al., 1999; Pagotto et al., 2001; Cota et al., 2003; 
Mackie, 2005).  In support, rimonabant dose-dependently increases basal and stressed-
induced plasma corticosterone secretion (Patel et al., 2004; Wade et al., 2006; Steiner et 
al., 2008).  Concurrently, CB1 -/- mice exhibit increased plasma corticosterone secretion 
in response to stress (Haller et al., 2002; Barna et al., 2004), and at rest (Barna et al., 
2004; Cota et al., 2007; Steiner et al., 2008).  Behaviorally, CB1 -/- mice exhibit an 
aggressive, and anxiety-like phenotype (Navarro et al., 1997; Martin et al., 2002), which 
may result from compensatory mechanisms associated with a life-long absence of CB1 
receptors (Wade et al., 2006).  Indeed, chronic exposure to unpredictable stress results in 
adaptive changes in the hippocampus, including a 50% reduction in CB1 receptor density, 
and a 40% reduction in 2-AG content (Hill et al., 2005b).   In contrast to attenuated CB1 
receptor signaling, enhancement of eCB signaling appears to dampen the stress response.  
Acute presentation of anxiogenic stimuli increases 2-AG and AEA content in the 
amygdala (Marsicano et al., 2002; Patel et al., 2004).  Administration of the FAAH 
inhibitors AM-404 or URB-597 both decrease plasma corticosterone in response to 
restraint stress (Patel et al., 2004), and FAAH -/- mice and URB-treated rodents exhibit 
anxiolytic-like effects  (Kathuria et al., 2003; Patel and Hillard, 2006; Naidu et al., 2007).   
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 There is evidence that the intensity of a stressor can impair or facilitate memory 
acquisition, and exhibits a U-shaped curve (McGaugh, 1985; Korneyev, 1997).  Mild, 
low-intensity stressors, such as handling or exposure to an intruder, appear to stimulate 
cognitive function and facilitate acquisition (Shors et al., 1992).  In contrast, severe 
stressors such as inescapable shock inhibit memory formation in rodents (Anderson and 
Paden, 1966; Jackson et al., 1980), and humans (Pitman, 1989).  One particular brain-
region exhibiting marked sensitivity to stress-induced alterations is the hippocampus.  
Specifically, dendritic atrophy and decrements in long-term potentiation have been 
reported following chronic exposure to stress (Galea et al., 1997; Alfarez et al., 2003).  In 
rodent models of cognition, these physiological changes appear to result in impairments 
of acquisition and reversal/extinction learning (Luine et al., 1993; Luine et al., 1994; 
Francis et al., 1995; de Quervain et al., 1998; Vasconcellos et al., 2003; Hill et al., 
2005b). Collectively, these reports suggest that eCB manipulations can affect cognitive 
processes by altering responding to stress, or vice versa.  In relation to the present work, 
it is difficult to distinguish the extent to which, if any, alterations in the physiological 
response to stress influence performance.  For example, the deficits in acquisition 
associated with CB1 -/- mice may be a result of a hyperresponsiveness to the stress of 
open-field exposure, deficits in cognitive processes such as consolidation, or both.  In 
addition, motor deficits associated with CB1 receptor deletion, such as reduced bone 
density in CB1 -/- mice on the C57 background , may result in poorer performance 
compared to CB1 +/+ mice (Tam et al., 2006).  The observation that CB1 -/- mice, and 
rimonabant-treated mice, consistently spent more time immobile than controls, supports 
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the involvement of eCB-mediated alterations in anxiety during acquisition of the task.  
Furthermore, in the aversive paradigm, FAAH -/- mice spent significantly less time 
immobile than FAAH +/+ mice.  Together, these results suggest that under aversive 
conditions, the eCB system is actively engaged in dampening the stress response elicited 
by aversive conditions.  However, acquisition was only affected in CB1 -/- and FAAH -/- 
mice, and rimonabant did not impair acquisition of the task under either reinforcement 
condition.  Thus, compensatory mechanisms associated with genetic deletion of the 
FAAH enzyme or CB1 receptor may be responsible for the alterations in acquisition 
learning.  Finally, it is unclear why FAAH -/- spent significantly less time immobile 
under aversive conditions, but spent significantly more time immobile under appetitive 
conditions.  However, mobility is a complicated phenotype and is affected by a wide 
range of factors including but not limited to fear and arousal.  As endocannabinoids are 
released on demand in response to stressors, it is tempting to speculate that appetitive 
conditions are insufficient to cause eCB release.  The resulting increase in eCB signaling 
under aversive conditions would produce an anxiolytic response, and is supported by the 
observation that subthreshold doses of THC produce anxiolytic-like effects (Valjent et 
al., 2002).     
 Comparing initial day one baseline acquisition data across studies reveals 
differences in initial acquisition performance between experiments.  However, as we 
treated each experiment as a separate entity, no analyses were performed comparing data 
between experiments.  Furthermore, these differences appear to be specific to individual 
experiments.  For example, comparing acquisition data from the first day of the appetitive 
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procedure (i.e. methods development and rimonabant during acquisition) reveals slightly 
different values.  However, in each case within group means and standard errors appear 
consistent, suggesting differences do not arise from distinct populations of ‘fast’ and/or 
‘slow’ learning subjects.  Regardless, we assume that these differences are an artifact 
produced by different cohorts of subjects, and do not affect the interpretation of the data. 
 It is unknown whether rimonabant will disrupt extinction learning in the 
appetitive task if administered during both acquisition and extinction.  In the aversive 
paradigm, rimonabant was administered during acquisition and extinction in one 
experiment, and only during extinction in a follow-up experiment.  However, in the 
appetitive model, rimonabant administration only occurred during extinction.  While we 
assumed from results in the aversive paradigm that administration of rimonabant during 
extinction is sufficient to disrupt extinction learning, the application of this conclusion to 
the appetitive condition deserves consideration.   
  There are three uncertainties regarding the data presented here that could be 
clarified in future studies.  First, it is unknown whether exposure to the Barnes maze task 
results in HPA axis activation.  Experiments designed to collect and measure plasma 
corticosterone at different time-points during acquisition, after handling, and at rest, 
would provide a framework for future experiments, as well as characterize the 
physiological consequence of acute and repeated Barnes maze exposure in relation to 
stress as well as associated adaptive changes in the stress response.  Alternatively, if the 
effects observed during acquisition reflect altered anxiety, supporting evidence may be 
procured via administration of a sub-threshold dose of a benzodiazepine.  Of course a 
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dose-response curve would be necessary as benzodiazepines have well-document 
amnesic effects.    
Second, experiments designed to characterize eCB content in relevant brain areas 
such as the hippocampus, amygdala, and PFC, would facilitate our understanding of how 
the eCB system responds to acute and repeated exposure to the aversive and appetitive 
Barnes maze task, and later, may aid the identification of purported adaptive changes 
associated with genetic deletion of the FAAH enzyme.  Alternatively, complementary 
approaches to manipulate the eCB system, aside from pharmacological drug 
administration, would provide convergent data for results from genetic knockouts.  For 
example, siRNA specific for CB1 or FAAH would create an acute genetic knockout with 
transient effects.  Thus, this approach would aid the distinction between effects associated 
with genetic inhibition, or adaptive changes resulting from the life-long absence of a 
gene.   
Third, attentional processes can affect performance during cognitive tasks, 
resulting in altered performance.  In the present context, it is unknown whether our 
observations result from abnormal attention to the context stimuli, rather than the task 
itself.  Future experiments utilizing a cued procedure, in which a salient proximal cue 
demarcates the location of the hidden goal, will allow us to demonstrate whether a deficit 
in acquisition occurs with preserved general attention, motoric abilities, and motivation 
(Whishaw and Tomie, 1987).   For example, septal lesions result in impaired acquisition 
of the homing board, and Morris water maze, resulting in longer latencies and path 
lengths to find the hidden goal (Kelsey and Landry, 1988; Brandner and Schenk, 1998).  
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Following the introduction of a salient cue, the deficits in acquisition were reversed, 
suggesting deficits in reference memory.  Introduction of the same methodology into the 
Barnes maze model would provide information regarding the nature of the acquisition 
effects reported here.  In the case of our CB1 -/- mice acquisition data, it appears unlikely 
that the deficits result from shifted attention to aversive stimuli, as the deficits were also 
observed in the absence of bright lights and air turbulence.  However, as mentioned, a 
cued procedure would also facilitate investigation into altered motor processes, or 
motivation.  As differences in running speed were observed in FAAH -/- mice, the 
necessity of running a cued procedure is underscored.   
Endocannabinoid-based pharmacotherapies to treat a wide range of disorders are 
under development.  As research in the field of endocannabinoids progresses, so does the 
evidence for pharmacotherapeutic potential.  Already, manipulations of this system hold 
potential for therapies in the fields of pain, inflammation, obesity, drug abuse, diabetes, 
anxiety, depression, and cognitive disorders.  The results presented here further support 
the hypothesis that the endocannabinoid system mediates the extinction of behaviors that 
are specific to aversive conditions, leaving extinction of learned behaviors in appetitively 
reinforced tasks intact.   While it remains questionable whether the physiological role of 
the endocannabinoid system is involved in other forms of positively reinforced (e.g., 
sexual) learning, the system’s impact on aversively motivated learning is unmistakable.  
These results underscore the importance of understanding a patient’s history prior to 
administering rimonabant or other cannabinoid receptor antagonists should they become 
therapeutically available.   Specifically, contraindication might include patients with a 
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history that includes abuse or traumatic events (e.g. combat, criminal assault, severe 
injury) that interfere with normal, daily functioning.   For example, post-traumatic stress 
disorder has been described as a failure of extinction learning (Rothbaum & Davis, 
2003).  Treatment of a patient suffering from post-traumatic stress disorder, or similar 
afflictions (e.g. panic attacks, obsessive-compulsive disorder, and adjustment disorder) 
would be difficult, if not impossible, following rimonabant administration.   Furthermore, 
administering a drug that interferes with normal extinction learning, such as rimonabant, 
might exacerbate such an illness.    
In contrast to the potential harm associated with rimonabant administration, and 
possibly CB1 antagonism in general, these results have an encouraging aspect.  First, the 
results suggest that therapies resulting in increased endocannabinoid signaling, as with a 
FAAH inhibitor or a cannabinoid receptor agonist, may accelerate extinction learning, 
thereby presenting a potential therapeutic treatment for psychiatric disorders that are 
hypothesized to include elements of maladaptive cognitive processes and an inability to 
adapt to a new environment (i.e., post-traumatic stress disorder [PTSD], phobias, and 
generalized anxiety disorder [GAD]) (Lutz, 2007).  In general, these disorders result from 
unpleasant prior experiences, are manifested as feelings of intense anxiety and panic, and 
persist due to inappropriate extinction (Milad et al., 2006).  Recently, Varvel et al., 
(2006) reported that FAAH -/- mice, and mice administered the FAAH inhibitor OL-135, 
displayed accelerated extinction learning in the Morris water maze, further underscoring 
the therapeutic potential of endocannabinoid based drugs. 
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  Goal of the 
Task 
Number of Holes Author Source of 
Motivation 
Species Experimental
Purpose 
Dependent measures   
Descend into 
escape box 
18 (Barnes, 1979) Bright lights Rats Evaluate 
senescence  
latency to enter, 
speed, strategy, 
distance, total errors, 
angle of deviation 
Descend into 
escape box 
40  (Bach et al., 
1995) 
Bright lights, 
tone 
Mice Evaluate CaMKII
-/- mice 
 Total errors, strategy, 
distance from tunnel, 
perseverative errors,  
Descend into 
escape box 
40 (Fox et al., 
1998) 
Bright lights Mice CCI induced 
cognitive deficits  
Latency to enter, 
strategy - % of trials 
used, total errors 
Descend into 
escape box 
16 (Pompl et al., 
1999) 
Bright lights/fan Mice  Assess APPsw 
mice in a new 
model 
latency to enter, total 
errors, error scale 
Descend into 
escape box 
40 (Inman-Wood et 
al., 2000) 
Bright 
lights/fan/tone; 
all turned off 
after completion 
of goal 
Mice  Prenatal exposure 
to cocaine 
Total errors, latency 
to enter, strategy, # of 
holes from target hole 
Descend into 
escape box 
12    (Miyakawa et 
al., 2001) 
Unknown Mice Evaluation of Ng 
-/- mice 
Latency to find, 
distance to find, total 
errors, time 
spent/hole, speed. 
Descend into 
escape box 
12 (Grootendorst et 
al., 2001) 
Return to home-
cage, sugar in 
home-cage 
Mice Stress and ApoE  
-/- mice 
Latency to find, 
velocity, distance, % 
time per zone (center, 
mid, tunnel, outer 
ring), strategy, total 
pokes 
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Goal of the 
Task 
Number of Holes Author Source of 
Motivation 
Species Experimental 
Purpose 
Dependent measures   
Descend into 
escape box 
36 (Paylor et al., 
2001) 
Bright lights Mice LHX5 -/- mice Latency to find, 
composite search 
score, composite 
search score, site 
errors 
Descend into 
escape box 
12 (Holmes et al., 
2002) 
Bright lights (?) Mice Behavioral 
profiles of inbred 
strains 
Errors to reach target, 
target hole preference 
index, speed, distance, 
Visits/hole, speed, 
distance  
Descend into 
escape box 
30  (Williams et al., 
2003) 
fruit loop in goal 
box or bright 
lights 
Rats Prenatal meth
exposure 
 latency to first hole, 
latency to find target 
hole, total errors 
Walk into 
escape tunnel 
12 (Koopmans et 
al., 2003) 
Escape tunnel 
allows access to 
home cage 
Mice  strain differences 
in new model 
Latency to enter, 
distance to find, total 
errors, speed, time in 
target zone 
Descend into 
escape box 
40 (Seeger et al., 
2004) 
Bright lights, 
tone 
Mice Evaluation of M2 
-/- mice 
Latency to enter, total 
errors, latency to 
enter, # perseverations 
Descend into 
escape box 
40 (Dawood et al., 
2004) 
Unknown Mice  Compare training 
paradigms 
latency to find, total 
errors prior to finding, 
Descend into 
escape box  
(same as 
Pompl et al.) 
16 (Bredy et al., 
2004) 
Bright lights/fan Mice  neonatal 
handling/paternal 
care in 
monogamous 
mice 
Latency to find , total 
errors prior to finding, 
time in target zone, 
target hole approaches 
Descend into 
escape box 
40   (Raber et al., 
2004) 
Bright lights, 
tone 
Mice Radiation
induced cognitive 
deficits 
Errors, distance from 
escape hole, strategy 
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Goal of the 
Task 
Number of Holes Author Source of 
Motivation 
Species Experimental 
Purpose 
Dependent measures   
Descend into 
escape box 
12 (Harrison et al., 
2006) 
Gentle handling Mice Spatial and non-
spatial search 
strategies in the 
Barnes maze 
Errors prior to 
finding, latency to 
find, distance to find, 
total errors, latency to 
enter, total distance, 
strategy - % of trials 
used, % time in target 
zone  
Descend into 
escape box 
20    (Barr et al., 
2007) 
Buzzer (80dB), 
bright lights. 
Mice Evaluation of
ApoER2 -/- mice. 
Latency to find, 
errors, perseverations, 
distance from first 
hole investigated to 
target hole, total 
errors, latency to 
enter. 
Descend into 
escape box 
40 (Dai et al., 
2007) 
Bright lights Mice Cognitive 
dysfunction in 
H1 and H2 -/- 
mice. 
Distance to enter. 
Descend into 
escape box 
40  (Hong et al., 
2007) 
Fans, bright 
light. 
Mice Assess Emx1 -/- 
mice 
Path-length, velocity, 
latency to find 
Descend into 
escape box 
24  (Mueller and
Bale, 2007) 
Bright lights 
and/or air 
turbulence 
and/or 100 dB 
noise 
Mice Prenatal stress on 
learning 
performance 
Latency to first hole, 
distance of first hole 
searched to target 
hole, errors, latency to 
find, errors after 
finding, search 
strategy, success. 
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Goal of the 
Task 
Number of Holes Author Source of 
Motivation 
Species Experimental 
Purpose 
Dependent measures   
Descend into 
escape box 
19    (O'Connor et 
al., 2007) 
Bright lights, 
aversive 
auditory 
stimulus 
rats Effects of
progesterone 
following 
traumatic brain 
injury. 
Latency to enter 
Descend into 
escape box 
20 (O'Tuathaigh et 
al., 2007) 
Litter from 
home cage and 
Honey Loops 
(food reward) in 
escape box.  
Bright Lights. 
Mice Assess NRG1 -/- 
mice 
Latency to enter, 
distance traveled, 
number of errors 
Descend into 
escape box 
20 (Prut et al., 
2007) 
Buzzer (80dB), 
bright lights. 
Mice Assess APP23 -/- 
mice 
Latency to enter, 
number of errors, 
search strategy 
Descend into 
escape box 
12 (Reiserer et al., 
2007) 
Gentle handling Mice Assess APPsw -/- 
mice  
omission errors, 
errors/distance/latency 
to find, total errors, 
strategy - % of trials 
used, % time in target 
zone 
Descend into 
escape box 
40  (Rueda-Orozco 
et al., 2007) 
White noise 
(90dB), bright 
lights 
Rats Endocannabinoid
mediation of 
search strategy 
 Total errors, % search 
strategy, mean time of 
performance, % errors 
in target zone, median 
of the distance. 
Descend into 
escape box 
18   (Simola et al., 
2008) 
Unknown Rats Assess perinatal
asphyxia in non-
spatial memory. 
 Latency to find, total 
errors. 
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Goal of the 
Task 
Number of Holes Author Source of 
Motivation 
Species Experimental 
Purpose 
Dependent measures   
Descend into 
escape box 
30 (Vorhees et al., 
2007) 
Bright lights Rats Developmental 
effects of 
MDMA on 
spatial learning. 
Latency to find, 
distance to find, total 
distance traveled. 
Descend into 
escape box 
8   (Xu et al., 2007) Ambient 
laboratory 
conditions 
Mice Assess age
differences in Tg-
SwDI -/- mice 
 Latency to find the 
escape hold  
Descend into 
escape box. 
12 (Ambree et al., 
2007) 
Bright lights Mice L-DA in murine 
models of 
Alzheimer’s 
(TgCRND8 -/- 
mice). 
Path length, latency to 
find, latency to enter, 
% time in target zone. 
Descend into 
escape box 
16 (Fabricius et al., 
2008) 
Bright lights, 
loud rock and 
techno music. 
Mice  Maternal 
separation on 
behavior and 
hippocampal 
neuronal count. 
Latency to find, 
distance traveled, 
error frequency, visits 
to target hole and 
adjacent two holes, 
search strategy. 
Descend into 
escape box. 
40 (Fedorova et al., 
2007) 
Bright lights. Mice Spatial learning 
following n-3 
fatty acid 
deficient diet. 
Distance, latency to 
enter, number of 
errors, total time 
mobile/immobile. 
Descend into 
escape tunnel 
12   (Moreau et al., 
2008) 
Tunnel leading 
to homecage 
Mice Behavioral
effects of p75-
Saporin 
immunotoxin. 
Visits to target/non-
target holes, latency to 
find, order of visited 
holes, repetitive 
errors. 
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Goal of the 
Task 
Number of Holes Author Source of 
Motivation 
Species Experimental 
Purpose 
Dependent measures   
Descend into 
escape box 
20 (Oliveira et al., 
2008) 
Bright lights Rats Involvement of 
polyamine 
binding sights at 
NMDAr in 
creatine-induced 
spatial learning 
enhancement. 
Latency to find, total 
errors. 
Descend into 
escape tunnel 
12  (Richter et al., 
2008) 
Tunnel leading 
to homecage, 
bright lights 
Mice Assess
TgCRND8 -/- 
mice in enriched 
environment. 
 Path length, latency to 
enter, time spent in 
target zone. 
Descend into 
escape box 
 
8(?)      (Trofimiuk and
Braszko, 2008) 
Unknown Rats Alleviation of
stress induced 
spatial memory 
impairments with 
St. Johns wort. 
Latency to find, total 
errors.  
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